STUDENT TRANSPORTATION INC. and SPINNER CAN ACQUIRECO INC. ARRANGEMENT AGREEMENT February 27, 2018

ARTICLE 6

CONDITIONS

ARTICLE 8

GENERAL PROVISIONS

any change affecting one or more of the industries thereof, in which the Company and/or its Subsidiaries operate;

any change, development or condition in or relating to global, national or regional political conditions (including any act of terrorism or any outbreak of hostilities or declared or undeclared war or any continuation, escalation or worsening thereof) or in general economic, business, banking, regulatory, financial, credit, currency exchange, interest rate, rates of inflation or capital market conditions in Canada, the United States or elsewhere;

any adoption, proposal or implementation of, or change in, Law, GAAP or regulatory accounting requirements or in the interpretation, application or non-application of the foregoing by any Governmental Entity;

any natural disaster or outbreaks of illness;

the failure, in and of itself, of the Company to meet any internal or public projections, forecasts, guidance or estimates of revenues, earnings, sales, margins or cash flows (it being understood that the causes underlying such failure may be taken into account in determining whether a Material Adverse Effect has occurred to the extent not otherwise excluded from the definition of Material Adverse Effect);

any action taken (or omitted to be taken) by Company or any of its Subsidiaries that is required by this Agreement or upon the written request or with the written consent of the Purchaser;

the negotiation, execution, announcement or performance of this Agreement or the consummation of the transactions contemplated hereby, the identity of Purchaser or its affiliates, or the communication by the Purchaser or its representatives of its plans or intentions with respect to the Company, its Subsidiaries or any of their assets, including any loss or threatened loss of, or adverse change or threatened adverse change in, the relationship of the Company or any of its Subsidiaries with any Governmental Entity or any of their current or prospective employees, customers, securityholders, financing sources, vendors, distributors, regulators, suppliers or partners arising as a consequence of any of the foregoing;

any litigation or threatened litigation relating to this Agreement;

any change or announcement of a potential change in the credit ratings in respect of the Company or any of its Subsidiaries or a change in any analysts’ recommendation or rating with respect to the Company (it being

understood that the causes underlying such change in ratings recommendations may be taken into account in determining whether a Material Adverse Effect has occurred to the extent not otherwise excluded from the definition of Material Adverse Effect); or

any change in the market price or trading volume of any securities of the Company or any of its Subsidiaries (it being understood that the causes underlying such change in market price or trading volume may be taken into account in determining whether a Material Adverse Effect has occurred to the extent not otherwise excluded from the definition of Material Adverse Effect), or any suspension of trading in securities generally on any securities exchange on which the securities of the Company or any of its Subsidiaries trade;

Liens or deposits for Taxes which are not due or delinquent or which are being contested in good faith by appropriate Proceedings and for which adequate accruals or reserves have been included in accordance with GAAP;

Liens under all existing security documents in connection with the Company’s or its Subsidiaries indebtedness reflected on the Company Financial Statements;

easements, rights of way, restrictions, restrictive covenants, servitudes and similar rights in real property, including rights of way and servitudes for highways and

other roads, railways, sewers, drains, gas and oil pipelines, gas and water mains, electric light, power, telephone, telegraph or cable television conduits, poles, wires and cables that, in each case, individually or collectively, do not materially adversely affect the value, marketability or use of the relevant property as it is being used at the date hereof, provided the same has been complied with in all material respects;

inchoate or statutory Liens of contractors, subcontractors, mechanics, workers, suppliers, materialmen, warehousemen, carriers and others in respect of the construction, maintenance, repair, operation or storage of Company Assets, or other Liens arising out of judgments or awards with respect to which an appeal or other Proceeding for review is being prosecuted;

municipal by-laws, regulations, zoning law, building or land use restrictions and other limitations imposed by any Governmental Entity having jurisdiction over real property;

Liens against furniture, leasehold improvements and equipment securing indebtedness incurred to finance the acquisition of such furniture, leasehold improvements or equipment;

pledges, deposits and Liens under worker’s compensation laws, employment insurance laws or similar legislation;

good faith deposits in connection with bids, tenders and contracts;

in respect of Company Assets which are real property, cost sharing, servicing, access, reciprocal and other similar agreements with neighbouring landowners and/or Governmental Entities that do not materially adversely affect the value, marketability or use of the relevant property as it is being used at the date hereof, provided the same have been complied with in all material respects;

in respect of any real property, any reservations, exceptions, limitations, provisos and conditions contained in the original Crown grant or patent;

any leases, licenses or occupancy agreements granted by the Company, its Subsidiaries and the Non-Controlled Entities over portions of the Company Assets that do not materially adversely affect the use of the relevant property as it is being used at the date hereof;

the rights of any lessee and, if applicable, any guarantor under any applicable operating or capital lease of personal property where the Company or any of its Subsidiaries is lessor (including for any School Buses and related operating equipment);

Liens securing debt incurred to finance the unpaid acquisition price of personal property, provided that such Liens do not encumber at any time any property other than the property provided by such debt, including refinancings thereof; and

any other immaterial defects, Liens or irregularities of title which do not interfere with the use of the properties or assets of the Company in the manner in which they are currently being used.

Headings, etc. The provision of a Table of Contents, the division of this Agreement into Articles and Sections and the insertion of headings are for convenient reference only and do not affect the construction or interpretation of this Agreement. Unless the contrary intention appears, references in this Agreement to an Article, Section, subsection, Paragraph or Schedule by number or letter or both refer to the Article, Section, subsection, Paragraph or Schedule, respectively, bearing that designation in this Agreement.

Currency. All references to dollars or to “$” are references to U.S. dollars, unless specified otherwise.

Gender and Number. Any reference to gender includes all genders. Words importing the singular number only include the plural and vice versa.

Certain Phrases, etc. The words (i) “including”, “includes” and “include” mean “including (or includes or include) without limitation,” (ii) “the aggregate of”, “the total of”, “the sum of”, or a phrase of similar meaning means “the aggregate (or total or sum), without duplication, of” and (iii) “or” shall not be exclusive (i.e., “or” shall mean “and/or”).

Capitalized Terms. All capitalized terms used in any Schedule or in the Company Disclosure Letter have the meanings ascribed to them in this Agreement.

Knowledge. Where any representation or warranty is expressly qualified by reference to the knowledge: (i) of the Company, it is deemed to refer to the actual knowledge, after reasonable inquiry, of the following Company Employees: ▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇, ▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇, ▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇ and ▇▇▇▇ ▇▇▇▇▇▇▇; or (ii) of the Purchaser, it is deemed to refer to the actual knowledge, after reasonable inquiry, of the following Persons: Olivier Renault, ▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇, ▇▇▇▇-▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇ and ▇▇▇▇▇ ▇▇▇▇▇.

Accounting Terms. Unless otherwise stated, all accounting terms are to be interpreted in accordance with GAAP and all determinations of an accounting nature in respect of the Company required to be made shall be made in a manner consistent with GAAP.

Statutes. Any reference to a statute refers to such statute and all rules, resolutions and regulations made under it, as it or they may have been or may from time to time be amended or re-enacted, unless stated otherwise; provided, that for purposes of any representations and warranties contained in this Agreement that are made as of a specific date or dates, references to any statute or other Law shall be deemed to refer to such statute or other Law, as amended, and to any rules or regulations made thereunder, in each case, as of such date.

Business Days. If the date on which any action is required or permitted to be taken under this Agreement by a Person is not a Business Day, such action shall be required or permitted to be taken on the next succeeding day which is a Business Day.

Time References. References to time are to local time in ▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇. When computing any time period in this Agreement, the following rules shall apply:

the day marking the commencement of the time period shall be excluded but the day of the deadline or expiry of the time period shall be included; and

any day that is not a Business Day shall be included in the calculation of the time period; however, if the day of the deadline or expiry of the time period falls on a day which is not a Business Day, the deadline or time period shall be extended to the next following Business Day.

Subsidiaries. To the extent any covenants or agreements relate, directly or indirectly, to a Subsidiary of the Company, each such provision shall be construed as a covenant by the Company to cause (to the fullest extent to which it is legally capable) such Subsidiary to perform the required action.

Schedules. The schedules attached to this Agreement form an integral part of this Agreement.

for the class(es) of Persons to whom notice is to be provided in respect of the Arrangement and the Company Meeting and for the manner in which such notice is to be provided (including the Common Shareholders, the Company Debentureholders and all holders of Incentive Securities);

that the requisite level of approval for the Arrangement Resolution shall be (a) two-thirds of the votes cast on such resolution by Common Shareholders present in person or represented by proxy at the Company Meeting, and (b) if, and to the extent required, a majority of the votes cast on such resolution by Common Shareholders present in person or represented by proxy at the Company Meeting excluding for this purpose votes attached to Common Shares held by persons described in items (a) through (d) of Section 8.1(2) of Multilateral Instrument 61-101 – Protection of Minority Security Holders in Special Transactions;

that, in all other respects, other than as ordered by the Court, the terms, restrictions and conditions of the Company Constating Documents, including quorum requirements and all other matters, shall apply in respect of the Company Meeting;

for the grant of the Dissent Rights to those Common Shareholders who are registered Common Shareholders as contemplated in the Plan of Arrangement;

for the notice requirements with respect to the presentation of the application to the Court for the Final Order;

that, subject to Section 2.3(i), the Company Meeting may be adjourned or postponed from time to time by the Company without the need for additional approval of the Court;

that the record date for Common Shareholders entitled to notice of and to vote at the Company Meeting will not change in respect of any adjournment or postponement of the Company Meeting, unless required by Law or the Court;

confirmation of the record date for the purposes of determining the Common Shareholders entitled to receive material and vote at the Company Meeting in accordance with the Interim Order; and

for such other matters as the Purchaser or the Company may reasonably require, subject to obtaining the prior consent of the other, such consent not to be unreasonably withheld or delayed, and subject to approval by the Court.

convene and conduct the Company Meeting in accordance with the Interim Order, the Company Constating Documents and Law as soon as reasonably practicable (and the Company agrees to use reasonable efforts to cause the Company Meeting to occur by the date that is 60 days from the date hereof) and, in this regard, the Company shall abridge, as necessary, any time periods that may be abridged under Securities Laws for the purpose of considering the Arrangement Resolution and for any other proper purpose as may be set out in the Company Circular and agreed to by the Purchaser, acting reasonably, and not adjourn, postpone or cancel (or propose the adjournment, postponement or cancellation of) the Company Meeting without the prior written consent of the Purchaser, except as required or permitted under Section 5.4(5) or Section 7.3(3), as required for quorum purposes (in which case the Company Meeting shall be adjourned or postponed and not cancelled), as required by Law or by a Governmental Entity or for the purpose of attempting to obtain the requisite approval for the Arrangement Resolution;

except as otherwise expressly contemplated or permitted by this Agreement, the Company shall not propose or submit for consideration at the Company Meeting any business other than the Arrangement without the Purchaser’s prior written consent, such consent not to be unreasonably withheld, conditioned or delayed;

use commercially reasonable efforts to solicit proxies in favour of the approval of the Arrangement Resolution and against any resolution submitted by any Person that is inconsistent with the Arrangement Resolution and the completion of any of the transactions contemplated by this Agreement, including, if so requested by the Purchaser, using a proxy solicitation services firm to solicit proxies in favour of the approval of the Arrangement Resolution;

provide the Purchaser with copies of or access to information regarding the Company Meeting generated by any proxy solicitation services firm retained by the Company, as requested from time to time by the Purchaser;

advise the Purchaser, at such times as the Purchaser may reasonably request and at least on a daily basis on each of the last ten Business Days prior to the date of the Company Meeting, as to the aggregate tally of the proxies received by the Company in respect of the Arrangement Resolution;

promptly advise the Purchaser of any known communication (written or oral) received from, or claims brought by (or threatened to be brought by), any Person in opposition to the Arrangement and/or any purported exercise or withdrawal of Dissent Rights by Common Shareholders and, subject to Law, provide the Purchaser with an opportunity to review and comment upon any written communications sent by or on behalf of the Company to any such Person and to participate in any discussions, negotiations or proceedings with or including any such persons;

not settle or compromise or agree to settle or compromise any purported exercise Dissent Rights by Common Shareholders, or make any payments with respect to any Dissent Right, without the prior written consent of the Purchaser, not to be unreasonably withheld, conditioned or delayed.

Subject to the Purchaser’s compliance with Section 2.4(4), the Company shall as promptly as reasonably practicable prepare and complete the Company Circular, together with any other documents required by Law in connection with the Company Meeting and the Arrangement, and the Company shall, promptly after obtaining the Interim Order, cause the Company Circular and such other documents to be filed with the applicable Securities Authorities and sent to each Common Shareholder and other Person as required by the Interim Order and Law (including the Company Debentureholders and all holders of Incentive Securities), in each case using all commercially reasonable efforts so as to permit the Company Meeting to be held by the date specified in Section 2.3(i).

On the mailing date of the Company Circular, the Company shall ensure that the Company Circular complies, in all material respects with the Interim Order and Law, does not contain any Misrepresentation (other than with respect to any information concerning the Purchaser, and its affiliates, any Equity Investor and the Financings, and furnished by or on behalf of the Purchaser or its representatives) and provides the Common Shareholders with sufficient information to permit them to form a reasoned judgement concerning the matters to be placed before the Company Meeting. Without limiting the generality of the foregoing, the Company Circular shall include: (i) a copy of the Fairness Opinion; (ii) a statement that the Board, after consulting with outside legal counsel and financial advisors, has determined that the Arrangement is in the best interests of the Company and recommends that Common Shareholders vote in favour of the Arrangement Resolution (the “Board Recommendation”); and (iii) a statement that,

to the knowledge of the Company, each director and executive officer of the Company who owns Common Shares intends to vote all such individual’s Common Shares in favour of the Arrangement Resolution.

The Company shall allow the Purchaser and its legal counsel a reasonable opportunity to review and comment on drafts of the Company Circular and other related documents, and shall give reasonable consideration to any comments made by the Purchaser and its legal counsel, and agrees that all information relating solely to the Purchaser included in the Company Circular must be in a form and content satisfactory to the Purchaser, acting reasonably.

The Purchaser shall provide to the Company in writing all information concerning the Purchaser, and its affiliates, and any Equity Investor and the Financings, as may be reasonably required by the Company in the preparation of the Company Circular or other related documents and shall ensure that such information does not contain, or cause the Company Circular to contain, any Misrepresentation.

The Purchaser hereby agrees to indemnify and save harmless the Company, its Subsidiaries and their respective Representatives from and against any and all liabilities, claims, demands, losses, costs, damages and expenses to which the Company, any of its Subsidiaries or any of their respective Representatives may be subject or may suffer as a result of, or arising from, any Misrepresentation or alleged Misrepresentation contained in any written information included in the Company Circular that was provided in writing by or on behalf of the Purchaser or its representatives for inclusion in the Company Circular concerning the Purchaser, and its affiliates, any Debt Financing Source or Equity Investor and the Financings, including as a result of any order made, or any inquiry, investigation or proceeding instituted by any Securities Authorities or any other Governmental Entity based on such a Misrepresentation or alleged Misrepresentation.

The Company and the Purchaser shall promptly notify each other if either of them becomes aware that the Company Circular contains a Misrepresentation or otherwise requires an amendment or supplement. The Parties shall co-operate in the preparation of any such amendment or supplement as required or appropriate, and the Company shall promptly mail, file or otherwise publicly disseminate any such amendment or supplement to those Persons to whom the Company Circular was sent pursuant to Section 2.4(1) and, if required by the Court or by Law, file the same with the Securities Authorities or any other Governmental Entity as required.

In accordance with the Plan of Arrangement, the Company shall take all actions necessary so that, at the time specified in the Plan of Arrangement, all unvested PSG Units outstanding immediately prior to the Effective Time shall immediately vest (with the PSG Units vesting based on a performance percentage of 100%) and each vested PSG Unit will be cancelled in exchange for cash in an amount equal to the Consideration, subject to the applicable Tax withholdings and other source deduction provisions of the Plan of Arrangement.

In accordance with the Plan of Arrangement, the Company shall take all actions necessary so that, at the time specified in the Plan of Arrangement, each DSU outstanding immediately prior to the Effective Time will be cancelled in exchange for cash in an

amount equal to the Consideration, subject to the applicable Tax withholdings and other source deduction provisions of the Plan of Arrangement.

The Articles of Arrangement shall implement the Plan of Arrangement. The Articles of Arrangement shall include the Plan of Arrangement.

The Arrangement shall become effective on the date upon which the Company and the Purchaser agree in writing as the Effective Date or, in the absence of such agreement, five Business Days following the satisfaction or waiver of all conditions to completion of the Arrangement set out in Article 6 (excluding conditions that, by their terms, cannot be satisfied until the Effective Date, but subject to the satisfaction or, where not prohibited, waiver of those conditions as of the Effective Date by the applicable Party or Parties for whose benefit such conditions exist) and the Arrangement shall be effective at the Effective Time on the Effective Date and will have all of the effects provided by applicable Law; provided that, if the Marketing Period has not ended at the time of the satisfaction or waiver of the conditions set out in Article 6 (excluding conditions that, by their terms, cannot be satisfied until the Effective Date, but subject to the satisfaction or, where not prohibited, waiver of those conditions as of the Effective Date by the applicable Party or Parties for whose benefit such conditions exist), then the Effective Date will take place instead on the earliest of (i) any Business Day during the Marketing Period as may be specified by the Purchaser on no less than three Business Days’ prior written notice to the Company, (ii) the next Business Day after the final day of the Marketing Period or (iii) such other date as the Purchaser and the Company may agree in writing, but subject in each case to the satisfaction or waiver of the conditions set out in Article 6 (excluding conditions that, by their terms, cannot be satisfied until the Effective Date, but subject to the satisfaction or, where not prohibited, waiver of those conditions as of the Effective Date by the applicable Party or Parties for whose benefit such conditions exist).

The closing of the Arrangement will take place at the offices of Goodmans LLP in Toronto, Ontario or at such other location as may be agreed upon by the Parties.

The Purchaser shall, following receipt of the Final Order but prior to the Effective Time, provide the Depositary or the Company (which amounts will then be provided to the Depositary), as applicable, with sufficient funds to be held in escrow (the terms and conditions of such escrow to be satisfactory to the Company and the Purchaser, each

acting reasonably) to satisfy the aggregate amount payable by the Company and the Purchaser, as applicable, to the Common Shareholders and Company Debentureholders as contemplated by the Plan of Arrangement, subject to applicable Tax withholdings and other source deduction provisions of the Plan of Arrangement.

If requested by the Company, the Purchaser shall, following receipt of the Final Order but prior to the Effective Time, provide the Company (or an escrow agent appointed for such purpose) with sufficient funds to be held in escrow (on terms and conditions to be agreed by the Company and the Purchaser, each acting reasonably) to satisfy the aggregate amount payable by the Company to holders of Incentive Securities, as contemplated by the Plan of Arrangement, subject to applicable Tax withholdings and other source deduction provisions of the Plan of Arrangement.

Any amounts provided by the Purchaser to the Company in Section 2.10(1) or Section 2.10(2) shall be provided by loan or other means on terms and conditions to be agreed by the Company and the Purchaser, each acting reasonably.

Except as set forth in the Company Disclosure Letter (it being expressly understood and agreed that the disclosure of any fact or item in any section of the Company Disclosure Letter shall be deemed to be an exception to (or, as applicable, disclosure for the purposes of) any other representation or warranty of the Company in this Agreement to which the relevance of such fact or item is reasonably apparent on its face) or in the

Company Filings (other than any disclosures contained under the captions “Risk Factors” or “Forward Looking Statements” and any other disclosures contained in such documents that are predictive, cautionary or forward-looking in nature), the Company represents and warrants to the Purchaser as set forth in Schedule D and acknowledges and agrees that the Purchaser is relying upon such representations and warranties in connection with the entering into of this Agreement.

The Purchaser agrees and acknowledges that, except as expressly set forth in Schedule D, neither the Company nor any other Person has made or makes any other representation and warranty (written or oral, express or implied, or at Law or in equity) with respect to the Company, its Subsidiaries, their respective businesses, the past, current or future financial condition or any of their assets, liabilities or operations, their past, current or future profitability or performance, individually or in the aggregate, the accuracy or completeness of any information furnished or made available to the Purchaser (or any officer, director, employee, Representative (including any financial or other advisor) or agent of the Purchaser) or any other Person in connection with the transactions contemplated hereby, and any such other representations or warranties are expressly disclaimed. Without limiting the generality of the foregoing, the Company expressly disclaims any representation or warranty that is not set forth in this Agreement. Neither the Company nor any other Person will have or be subject to any liability or indemnification obligation to the Purchaser or any other Person resulting from the distribution or failure to distribute to the Purchaser, or the Purchaser’s use of, any information, including any information, documents, projections, estimates forecasts of other material made available to Purchaser in any physical data room, in the Company Data Room Information or otherwise and maintained by the Company for purposes of the transactions contemplated by this Agreement or management presentations in expectation of the transactions contemplated by this Agreement, unless and to the extent any such information is expressly included in a representation or warranty contained in Schedule D.

The representations and warranties of the Company contained in this Agreement shall not survive the completion of the Arrangement and shall expire and be terminated at the earlier of the Effective Time and the termination of this Agreement in accordance with its terms.

The Purchaser represents and warrants to the Company as set forth in Schedule E and acknowledges and agrees that the Company is relying upon such representations and warranties in connection with the entering into of this Agreement.

Except for the representations and warranties set forth in this Agreement, neither the Purchaser nor any other Person has made or makes any other express or implied representation and warranty, either written or oral, on behalf of the Purchaser.

The representations and warranties of the Purchaser contained in this Agreement shall not survive the completion of the Arrangement and shall expire and be terminated at the

earlier of the Effective Time and the termination of this Agreement in accordance with its terms.

The Company covenants and agrees that, during the period from the date of this Agreement until the earlier of the Effective Time and the time that this Agreement is terminated in accordance with its terms, except (i) with the prior written consent of the Purchaser (such consent not to be unreasonably withheld, conditioned or delayed), (ii) as required or permitted by this Agreement (including the Plan of Arrangement), (iii) as required by Law, or (iv) as set out in the Company Disclosure Letter, the Company shall, and shall cause its Subsidiaries to, conduct their business in the Ordinary Course and in accordance with applicable Laws, and the Company shall use commercially reasonable efforts to maintain and preserve its and its Subsidiaries’ business organization, assets, goodwill, employment relationships (as a group) and business relationships with other Persons with which the Company or any of its Subsidiaries have business relations.

Without limiting the generality of Section 4.1(1), the Company covenants and agrees that, during the period from the date of this Agreement until the earlier of the Effective Time and the time that this Agreement is terminated in accordance with its terms, or any earlier time set forth in this Section 4.1(2), except (i) with the express prior written consent of the Purchaser (such consent not to be unreasonably withheld, conditioned or delayed), (ii) as required or permitted by this Agreement (including the Plan of Arrangement), (iii) as required by Law, or (iv) as set out in the Company Disclosure Letter, the Company shall not, and the Company shall not permit any of its Subsidiaries to, directly or indirectly:

amend the Company Constating Documents or amend the notice of articles, articles, articles of incorporation, articles of amalgamation, articles of continuance, by-laws, declaration of trust, partnership agreement or similar organizational documents of any Subsidiary of the Company;

adjust, split, combine, reclassify or amend any term of any securities of the Company or any of its Subsidiaries;

redeem, repurchase or otherwise acquire or offer to redeem, repurchase or otherwise acquire any securities of the Company or any of its Subsidiaries;

issue, grant, deliver, sell, pledge or otherwise encumber (other than Permitted Liens) or authorize the issuance, grant, delivery, sale, pledge or other encumbrance of (other than Permitted Liens), or otherwise modify the terms of, any Common Shares or any other equity or voting interests or any options, warrants or similar rights exercisable or exchangeable for or convertible into Common Shares, except for (A) the issuance of Common Shares issuable upon the exercise or settlement of the outstanding Incentive Securities or the

conversion of the outstanding Company Debentures, in each case in accordance with their terms, (B) transactions between two or more Persons each of whom is a wholly-owned Subsidiary of the Company, or between the Company and one or more Persons each of whom is a wholly-owned Subsidiary of the Company, or (C) as required under any existing Material Contracts disclosed in the Company Disclosure Letter or (D) pursuant to the Company’s dividend reinvestment plan;

Declare, set aside or pay any dividend or other distribution or payment in cash, securities or property with respect to any class of securities (which, for greater certainty, does not include payments made in accordance with the terms of the PSG Units and DSUs in existence as of the date hereof or any cash dividend by the Company), except for between two or more Persons each of whom is a wholly owned Subsidiary of the Company, provided that any intercompany indebtedness existing between such Persons has first been repaid in full, provided further that, if on or after the date of this Agreement but prior to the Effective Time or termination of this Agreement, the Company sets a record date for any cash dividend or other cash distribution on the Common Shares that is prior to the Effective Time and is not, or is in excess of, (A) regular monthly cash dividends consistent with past practice and the Company’s dividend policy paid to Common Shareholders on March 15, 2018, April 16, 2018, May 15, 2018, June 15, 2018 and July 15, 2018, each in an amount of $0.03667 per Common Share, and (B) pursuant to the Company’s dividend reinvestment plan, (each of (A) and (B) a “Contemplated Distribution”) or the Company pays any cash dividend or other cash distribution on the Common Shares prior to the Effective Time that is not, or is in excess of, a Contemplated Distribution: (I) to the extent that the amount of such cash dividends or cash distributions per Common Share does not exceed the Consideration, the Consideration shall be reduced by the amount of such cash dividends or distributions; and (II) to the extent that the amount of such cash dividends or cash distributions per Common Share exceeds the Consideration, such excess amount shall be placed in escrow for the account of Purchaser or another Person designated by Purchaser;

acquire (by merger, consolidation, acquisition of shares or assets (not including capital expenditures permitted under (xi) below) or otherwise), directly or indirectly, in one transaction or in a series of related transactions, any other Person or any equity interests therein, or any assets, securities, properties, interests or businesses, except for acquisitions having a value of less than $10,000,000 per transaction and in the aggregate of less than $15,000,000;

reorganize, restructure, recapitalize, amalgamate or merge with any other Person, except between or among two or more wholly owned Subsidiaries of the Company or between or among the Company and one or more of its wholly owned Subsidiaries;

adopt a plan of liquidation or resolutions providing for its liquidation or dissolution, except between or among two or more wholly owned Subsidiaries of

the Company or between or among the Company and one or more of its wholly owned Subsidiaries;

sell, pledge, licence, lease or otherwise transfer any Company Assets or any interest in any Company Assets, except for (A) Company Assets sold, leased or otherwise transferred in the Ordinary Course and having a value individually of less than $1,000,000 and in the aggregate of less than $5,000,000, (B) obsolete, damaged or destroyed assets, or (C) a transaction between two or more Persons each of whom is a wholly-owned Subsidiary of the Company or between the Company and one or more Persons, each of whom is a wholly-owned Subsidiary of the Company;

grant any Lien (other than Permitted Liens) on any Company Assets;

make any capital expenditures or commitment to do so except for: (A) expenditures or commitments relating to the maintenance of its assets that, in the aggregate, do not exceed $15,000,000, (B) expenditures or commitments required pursuant to Contracts not disclosed in the Company Disclosure Letter that, in the aggregate, do not exceed $10,000,000, or (C) expenditures or commitments required pursuant to any other Contract disclosed in the Company Disclosure Letter;

(A) make any material Tax election, information schedule, return or designation other than in the Ordinary Course and consistent with past practice, (B) settle or compromise any material Tax claim, assessment, reassessment or liability, (C) file any amended Tax Return, (D) enter into any agreement with a Governmental Entity with respect to Taxes, (E) enter into or change any Tax sharing, Tax advance pricing agreement, Tax allocation or Tax indemnification agreement, (F) surrender any right to claim a material Tax abatement, reduction, deduction, exemption, credit or refund, (G) consent to the extension or waiver of the limitation period applicable to any Tax matter, (H) amend or change any of its methods for reporting income, deductions or accounting for income Tax purposes, (I) knowingly take any action or knowingly permit inaction or knowingly enter into any transaction that could reasonably be expected to have the effect of materially reducing or eliminating the amount of the Tax cost “bump” pursuant to paragraphs 88(1)(c) and 88(1)(d) of the Tax Act in respect of the securities of any affiliates or Subsidiaries of the Company and other non-depreciable capital property owned by the Company or any of its Subsidiaries on the date hereof upon an amalgamation or winding-up of the Company or any of its Subsidiaries (or any of their respective successors), or (J) in respect of the Company or any Subsidiary that is a resident of Canada for purposes of the Tax Act make any “investment” (within the meaning of subsection 212.3(10) of the Tax Act) in a corporation that is not resident in Canada (within the meaning of the Tax Act);

prepay any long-term indebtedness before its scheduled maturity, other than repayments under the Company’s or any of its Subsidiaries’ existing credit facilities or in connection with actions otherwise permitted by Section 4.1;

incur any indebtedness for borrowed money, or assume or otherwise become liable, in one transaction or in a series of related transactions, with respect to any indebtedness for borrowed money or guarantees thereof, in an amount, on a per transaction or series of related transactions basis, in excess of $5,000,000 in the aggregate, except (A) indebtedness under any Existing Credit Facilities or any credit facility hereafter created pursuant to clause (D) below, (B) indebtedness owing by the Company or a wholly-owned Subsidiary of the Company to the Company or to another wholly-owned Subsidiary of the Company, (C) indebtedness required to be incurred by the terms of any joint venture agreement or other agreement with third party co-investors disclosed in the Company Disclosure Letter, (D) in connection with the refinancing of indebtedness outstanding on the date hereof, (E) in connection with actions otherwise permitted by Section 4.1, or (F) any guarantee by the Company of indebtedness of the wholly-owned Subsidiaries of the Company or any guarantee by the wholly-owned Subsidiaries of the Company of indebtedness of the Company or any of the wholly-owned Subsidiaries of the Company;

enter into any interest rate, currency, equity or commodity swaps, ▇▇▇▇▇▇, derivatives, forward sales contracts or similar financial instruments, other than in the Ordinary Course;

except as may be required by applicable Law or the terms of any existing Employee Plan or Contract as of the date hereof: (A) increase any severance, change of control or termination pay to (or amend any existing arrangement in relation thereto with) any director or officer of the Company or any of its Subsidiaries or materially increase any severance, change of control or termination pay to (or amend any existing arrangement in relation thereto with) any other Company Employee; (B) enter into any employment, deferred compensation or other similar agreement (or amend any such existing agreement) with any director or officer of the Company or, other than in the Ordinary Course, any Company Employee (other than a director or officer); (C) increase compensation, retention or incentive compensation or other benefits payable to any director or officer of the Company or any of its Subsidiaries or, other than in the Ordinary Course, any Company Employee (other than a director or officer) or independent contractor; (D) loan or advance money or other property by the Company or its Subsidiaries to any of their present or former directors, officers or Company Employees; (E) establish, adopt, enter into, amend or terminate any Employee Plan or any equity-based compensation arrangement, including the PSG Plan and the DSU Plan (or any plan, agreement, program, policy, trust, fund or other arrangement that would be an Employee Plan if it were in existence as of the date hereof) or collective bargaining agreement; (F) grant any equity-based awards; or (G) increase, or agree to increase, any funding obligation or accelerate, or agree to accelerate, the timing of any funding contribution under any Employee Plan;

make any change in the Company’s methods of accounting, except as required by GAAP (or any interpretation thereof) or pursuant to written instructions, comments or orders from any applicable Securities Authority;

waive, release, assign, settle or compromise any Proceeding in a manner that could require a payment by, or release another Person of an obligation to, the Company or any of its Subsidiaries in excess of $1,000,000 individually or $3,000,000 in the aggregate, or which could reasonably be expected to have a Material Adverse Effect;

amend or modify in any material respect, or extend, renew, terminate or waive any material right under, any Material Contract or enter into, amend or modify in any material respect any contract or agreement that would be a Material Contract if in effect on the date hereof;

sell, dispose of, transfer, or acquire any interest in any real property; or

agree, resolve or otherwise commit, whether or not in writing, to do any of the foregoing.

The Company shall use its reasonable commercial efforts to cause its current insurance (or reinsurance) policies, or substantially similar or better policies, to be maintained in effect in the Ordinary Course.

Nothing contained in this Agreement will give the Purchaser, directly or indirectly, the right to direct or control the Company’s business and operations prior to the Effective Date. Prior to the Effective Date, the Company will exercise, consistent with the terms of this Agreement, complete control and supervision over its business and operations. Nothing in this Agreement, including any of the restrictions set forth herein, will be interpreted in such a way as to place any Party in violation of applicable Law.

Subject to the terms and conditions of this Agreement, the Company shall, and shall cause its Subsidiaries to, use commercially reasonable efforts to perform all obligations required to be performed by the Company or any of its Subsidiaries under this Agreement, cooperate with the Purchaser in connection therewith, and do all such other acts and things as may be necessary or desirable to consummate and make effective, as soon as reasonably practicable, the Arrangement and, without limiting the generality of the foregoing, the Company shall and, where appropriate and shall cause its Subsidiaries to:

other than in connection with obtaining the Required Regulatory Approvals, which approvals shall be governed by the provisions of Section 4.4, use its commercially reasonable efforts to satisfy all conditions precedent in this Agreement and take all steps set forth in the Interim Order and Final Order applicable to it and comply promptly with all requirements imposed by Law on it with respect to this Agreement or the Arrangement;

other than in connection with obtaining the Required Regulatory Approvals, which approvals shall be governed by the provisions of Section 4.4, use its commercially reasonable efforts to obtain and maintain all third party or other consents, waivers, permits, exemptions, orders, approvals, agreements, amendments or confirmations that are necessary or advisable under any Contract to permit the consummation of the transactions contemplated by this Agreement or required in order to maintain any such Contract in full force and effect following completion of the Arrangement, in each case on terms satisfactory to the Purchaser, acting reasonably, and without paying or providing a commitment to pay any consideration in respect thereof without the prior written consent of the Purchaser (it being expressly agreed by the Purchaser that no such consent, waiver, permit, exemption, order, approval, agreement, amendment or confirmation shall be a condition to the closing of the Arrangement);

other than in connection with obtaining the Required Regulatory Approvals, which approvals shall be governed by the provisions of Section 4.4, use its commercially reasonable efforts to, (a) effect all necessary registrations, filings and submissions of information required by Governmental Entities from the Company and its Subsidiaries relating to the Arrangement (it being expressly agreed by the Purchaser that no such registration, filing or submission of information shall be a condition to the closing of the Arrangement), and (b) upon reasonable consultation with the Purchaser, oppose, lift or rescind any injunction, restraining or other order, decree or ruling seeking to restrain, enjoin or otherwise prohibit or adversely affect the consummation of the Arrangement and defend, or cause to be defended, any Proceedings to which it is a party or brought against it or its directors or officers challenging the Arrangement or this Agreement or the transactions contemplated thereby, including seeking to have any stay or temporary restraining order entered by any court or other Governmental Entity vacated or reserved, and the avoidance of each and every impediment under any antitrust, merger control, competition or trade Law that may be asserted by a Governmental Entity with respect to the Arrangement so as to enable closing to occur as soon as reasonably practicable (provided, that neither the Company nor any of its Subsidiaries shall consent to the entry of any judgment or settlement with respect to any such Proceeding without the prior written approval of the Purchaser, not to be unreasonably withheld, conditioned or delayed) (it being expressly agreed by the Purchaser that the sole conditions to closing with respect to the subject matter of this clause (b) are set out in Article 6); and

not take any action or refrain from taking any commercially reasonable action, or permit any action to be taken or any commercially reasonable action not be taken, which is inconsistent with this Agreement or which would reasonably be expected to prevent, materially delay or otherwise impede the consummation of the Arrangement; and

use all commercially reasonable efforts to assist in causing each member of its Board and the board of directors of each of its wholly-owned Subsidiaries, and the Company’s or its Subsidiaries’ designated or nominated directors on the board of

directors (or equivalent body) of each of its non-wholly owned Subsidiaries (in each case to the extent requested by the Purchaser) to be replaced by Persons designated or nominated, as applicable, by the Purchaser effective as of the Effective Time.

The Company shall promptly notify the Purchaser in writing, of:

any Material Adverse Effect after the date hereof;

any notice or other communication from any Person alleging that the consent (or waiver, permit, exemption, order, approval, agreement, amendment or confirmation) of such Person (or another Person) is or may be required in connection with this Agreement or the Arrangement or the transactions contemplated hereby or thereby;

unless prohibited by Law, any notice or other communication from any Person (other than Governmental Entities in connection with the Required Regulatory Approvals, which shall be addressed as contemplated by Section 4.4) in connection with this Agreement (and the Company shall contemporaneously provide a copy of any such written notice or communication to the Purchaser); or

any Proceeding commenced or, to the Company’s knowledge, threatened against, relating to or involving or otherwise affecting this Agreement or the Arrangement.

Subject to the terms and conditions of this Agreement, the Purchaser shall and shall cause its affiliates to use commercially reasonable efforts perform all obligations required to be performed by it under this Agreement, cooperate with the Company in connection therewith, and do all such other acts and things as may be necessary or desirable to consummate and make effective, as soon as reasonably practicable, the Arrangement and, without limiting the generality of the foregoing, the Purchaser shall:

other than in connection with obtaining the Required Regulatory Approvals, which approvals shall be governed by the provisions of Section 4.4, use its commercially reasonable efforts to satisfy all conditions precedent in this Agreement and take all steps set forth in the Interim Order and the Final Order applicable to it and comply promptly with all requirements imposed by Law on it with respect to this Agreement or the Arrangement;

other than in connection with obtaining the Required Regulatory Approvals, which approvals shall be governed by the provisions of Section 4.4, use its commercially reasonable efforts to effect all necessary registrations, filings and submissions of information required by Governmental Entities from it relating to the Arrangement as soon as reasonably practicable; and

other than in connection with obtaining the Required Regulatory Approvals, which approvals shall be governed by the provisions of Section 4.4, use its

commercially reasonable efforts, upon reasonable consultation with the Company, to oppose, lift or rescind any injunction, restraining or other order, decree or ruling seeking to restrain, enjoin or otherwise prohibit or adversely affect the consummation of the Arrangement and defend, or cause to be defended, any Proceedings to which it is a party or brought against it or its directors or officers challenging the Arrangement or this Agreement or the transactions contemplated thereby, including seeking to have any stay or temporary restraining order entered by any court or other Governmental Entity vacated or reserved, and the avoidance of each and every impediment under any antitrust, merger control, competition or trade Law that may be asserted by a Governmental Entity with respect to the Arrangement so as to enable closing to occur as soon as reasonably practicable; provided, that the Purchaser shall not consent to the entry of any judgment or settlement with respect to any such Proceeding without the prior written approval of the Company, not to be unreasonably withheld, conditioned or delayed.

The Purchaser shall promptly notify the Company orally and, if requested, in writing of:

any notice or other communication from any Person (other than Governmental Entities in connection with the Required Regulatory Approvals, which shall be addressed as contemplated by Section 4.4) alleging that the consent (or waiver, permit, exemption, order, approval, agreement, amendment or confirmation) of such Person (or another Person) is or may be required in connection with this Agreement or the Arrangement or the transactions contemplated hereby or thereby;

unless prohibited by Law, any notice or other communication from any Governmental Entity in connection with this Agreement (and the Purchaser shall contemporaneously provide a copy of any such written notice or communication to the Company); or

any Proceedings commenced or, to the Purchaser’s knowledge, threatened against, relating to or involving or otherwise affecting the Purchaser or its affiliates or their respective assets, in each case to the extent that such Proceeding would reasonably be expected to impair, impede, materially delay or prevent the Purchaser from performing its obligations under this Agreement.

The Purchaser shall provide assistance as may reasonably be required by the Company for the purposes of completing the Company Meeting.

The Purchaser shall, and shall cause its affiliates to, use reasonable best efforts to take, or cause to be taken, all actions, and do, or cause to be done, all things necessary, proper or advisable to arrange and obtain the proceeds of the Debt Financing at or prior to the Effective Date, including using its reasonable best efforts to: (i) maintain in effect the Debt Commitment Letter in accordance with its terms (except for amendments, supplements, modifications, replacements or waivers not prohibited by this Agreement); (ii) negotiate and enter into definitive agreements with respect to the Debt Financing on the respective terms and conditions as promptly as practicable after the date hereof

(including any “market flex” provisions applicable thereto) contained in the Debt Commitment Letter or on other terms not less favorable to Purchaser than the respective terms and conditions (including any “market flex” provisions applicable thereto) contained in the respective Debt Commitment Letter; provided that such other terms could not reasonably be expected to delay or hinder the consummation of the Arrangement, (iii) satisfy on a timely basis (taking into account the anticipated timing of the Marketing Period) or obtain the waiver of all conditions to funding in the Debt Commitment Letter (or definitive agreements entered into with respect to the Debt Commitment Letter) applicable to Purchaser and consummate the Debt Financing at or prior to the Effective Time; and (iv) enforce its rights under the Debt Commitment Letter in the event of a breach by any party thereto.

The Purchaser shall, and shall cause its affiliates to, use reasonable best efforts to take, or cause to be taken, all actions, and do, or cause to be done, all things necessary, proper or advisable to arrange and obtain the proceeds of the Equity Financing at or prior to the Effective Date, including using its reasonable best efforts to: (i) maintain in effect the Equity Commitment Letter in accordance with its terms; (ii) satisfy on a timely basis all conditions to funding in the Equity Commitment Letter, except to the extent dependent on the compliance of the Company with its obligations under this Agreement; (iii) consummate the Equity Financing contemplated by the Equity Commitment Letter; (iv) in the event that all conditions to the Equity Financing have been satisfied or waived, cause the Equity Investors to fund their respective commitments in accordance with the Equity Financing required to consummate the transactions contemplated by this Agreement on or prior to the Effective Date; and (v) enforce its rights under the Equity Commitment Letter in the event of a breach by any party thereto.

The Purchaser shall not amend, alter or replace, or agree to amend, alter or replace, or permit the amendment, alteration or replacement of the Commitment Letters or any definitive agreement or documentation referred to in Section 4.3(4) or Section 4.3(5) in any manner that would (i) reduce (or have the effect of reducing) the aggregate amount of the Debt Financing (including by changing the amount of fees to be paid or original issue discount) or Equity Financing (ii) imposes new or additional conditions or otherwise expands, amends or modifies any of the conditions to the receipt of any portion of the Financings, (iii) or would reasonably be expected to (A) prevent or materially impair or delay the availability of the Debt Financing or the Effective Time when required by Section 2.9(1), (B) make the funding of the Financings (or satisfaction of the conditions to obtaining the Financings) less likely to occur or (C) adversely impact the ability of Purchaser to enforce its rights against other parties to the Debt Commitment Letter or Equity Commitment Letter, and shall not make any amendment to or replacement of the Equity Commitment Letter to effect (x) the replacement of any Equity Investor or (y) the withdrawal of any Equity Investor (it being understood that, in no event shall the foregoing prohibit (1) any amendment to the Debt Commitment Letter to reflect the application of any “market flex” terms or to add additional arrangers, bookrunners, agents or other Lenders as party thereto, in each case, to the extent such amendment does not result in any of the matters described in clauses (A), (B) and (C) above, or (2) any amendment to or replacement of the Equity Commitment Letter to effect (I) the replacement of any Equity Investor (other than CDPQ) with a successor Equity Investor

who has sufficient available funds to satisfy its payment obligations under the Equity Commitment Letter so long as such successor Equity Investor otherwise agrees to substantially the same terms and conditions as such original Equity Investor under the Equity Commitment Letter, or (II) the withdrawal of any Equity Investor (other than CDPQ) so long as the Equity Financing from CDPQ or the Debt Financing is correspondingly increased by the commitment amount of such withdrawing Equity Investor), in each case, to the extent such amendment does not result in any of the matters described in clauses (A), (B) and (C) above. The Purchaser shall promptly notify the Company in writing of (and such written notice shall include reasonable details related to, and reasons for, any of the following): (i) the expiration, breach, repudiation or termination (or anticipated, attempted, threatened or purported repudiation or termination, whether or not valid and whether or not in writing) of the Commitment Letters for any reason; (ii) receipt of written notice of the refusal of any Lender or, as applicable, Equity Investor to provide, or of any stated intent by any such Lender or Equity Investor to refuse to provide, the full Financing contemplated by the Commitment Letters, in each case, notwithstanding the efforts of the Purchaser to satisfy its obligations under Section 4.3(4), Section 4.3(5) or this Section 4.3(6); or (iii) for any reason, all or any portion of the Financings becoming unavailable, or is expected, or would reasonable be expected to, become unavailable, on the terms and conditions contemplated in any Commitment Letters (including any executed fee letter related to the Debt Commitment Letter). In such event, the Purchaser shall, in consultation with the Company, use its reasonable best efforts to promptly arrange for the same or alternative financing (or for additional financing from the original Lenders or any original Equity Investor) to replace the Financing contemplated by such expired, repudiated or terminated commitments or arrangements or for which such Lender or Equity Investor has refused to provide, which alternative financing would not reasonably be expected to prevent, materially impair or delay the consummation of the Arrangement when required pursuant to Section 2.9(1). The Purchaser shall deliver correct and complete copies of any modified or replacement Commitment Letters to the Company as promptly as practicable following the execution thereof (provided, that the existence and/or amount of “market flex” provisions, fees, pricing terms and pricing caps and other economic terms set forth in any such agreement may be redacted). In the event that any Commitment Letter is amended, restated, amended and restated, supplemented, modified, or replaced, the term “Debt Commitment Letter” or “Equity Commitment Letter” (as applicable) as used herein shall be deemed to include the new or amended commitment letters or arrangements described in this Section 4.3(6) to the extent then in effect, the term “Debt Financing”, “Equity Financing” and “Financings” as used herein shall be deemed to include the applicable financing contemplated by any such new or amended commitment letters or arrangements, and the term “Lenders” and “Equity Investors” as used herein shall be deemed to include the applicable lenders or sources of equity financing contemplated by any such new or amended commitment letters or arrangements.

The Purchaser acknowledges and agrees that except (i) as provided in Section 4.3(6) and Section 4.8 and (ii) for any condition to the consummation of the Debt Financing resulting from a breach of any representation or warranty of the Company set forth in this Agreement, none of the Company or any of its affiliates or Representatives shall have any responsibility for any financing that the Purchaser may raise in connection with the

transactions contemplated hereby. The Purchaser also acknowledges and agrees that the Purchaser’s obtaining financing is not a condition to any of its obligations hereunder, regardless of the reasons why financing is not obtained or whether such reasons are within or beyond the control of the Purchaser. For the avoidance of doubt, if any financing referred to in Section 4.3(4), Section 4.3(5) and Section 4.3(6) is not obtained (other than due to the failure of a condition to the consummation of the Debt Financing resulting from a breach of any representation, warranty, covenant or agreement of the Company set forth in this Agreement), the Purchaser shall continue to be obligated to consummate the transactions contemplated by this Agreement, subject to and on the terms contemplated by this Agreement.

The Purchaser shall consult with and keep the Company informed in reasonable detail of the status of its efforts to arrange the Financings. None of Purchaser, the Equity Investors or any of their respective Affiliates shall take any action that could reasonably be expected to delay or prevent the consummation of the transactions contemplated hereby, including the Financings.

As soon as reasonably practicable after the date hereof, the Purchaser and the Company shall identify any Regulatory Approvals deemed by them to be necessary to discharge their respective obligations under this Agreement and each Party, or where appropriate, the Parties jointly, shall make all notifications, filings, applications and submissions with any Governmental Entity required or advisable, and shall use its commercially reasonable efforts to obtain and maintain the Regulatory Approvals, including the Required Regulatory Approvals.

In connection with obtaining the Required Regulatory Approvals, as promptly as practicable, and in any event within ten Business Days after the date of this Agreement, (i) the Purchaser shall submit a letter to the Commissioner of Competition in support of and requesting an advance ruling certificate pursuant to Subsection 102(1) of the Competition Act or, in lieu thereof, a No Action Letter, (ii) each Party shall, or shall cause its relevant Subsidiaries to, file its respective notification pursuant to Section 114 of the Competition Act (“Competition Notification”), unless the Parties mutually agree in writing to either not file a Competition Notification or on an alternative period of time in which to file a Competition Notification, and (iii) each Party shall, or shall cause its relevant Subsidiaries to, file its respective Notification and Report Form (“HSR Form”) pursuant to the HSR Act. Each Party shall, or shall cause its relevant Subsidiaries to make any other notification, submission or application filing that is necessary in order to obtain the Required Regulatory Approvals (if any) as promptly as practicable.

The Parties shall cooperate with one another in connection with obtaining the Regulatory Approvals including providing or submitting on a timely basis, and as promptly as practicable, all documentation and information that is required, or in the opinion of the Company and Purchaser, acting reasonably, advisable, in connection with obtaining the Regulatory Approvals and use their commercially reasonable efforts to ensure that such information does not contain a Misrepresentation; provided, however, that nothing in this

provision shall require a Party to provide information that is not in its possession or not otherwise reasonably available to such Party.

All filing fees and applicable Taxes payable for or in respect of any application, notification or other filing made to any Governmental Entity in respect of any Required Regulatory Approval shall be the sole responsibility of the Purchaser.

With respect to obtaining the Required Regulatory Approvals, each Party shall:

not extend or consent to any extension of any applicable waiting or review period or enter into any agreement with a Governmental Entity to not consummate the transactions contemplated by this Agreement, except upon the prior consent of the other Party, such consent not to be unreasonably withheld, conditioned or delayed;

cooperate with the other Party and keep the other Party fully informed as to the status of and the processes and proceedings relating to obtaining the Required Regulatory Approvals and shall promptly notify the other Party of written or oral communications from a Governmental Entity relating to any Required Regulatory Approval and provide the other Party with copies thereof;

use its commercially reasonable efforts to respond to any inquiries or requests received from a Governmental Entity in respect of any Required Regulatory Approval at the earliest practicable date;

permit the other Party to review in advance any proposed written communications of any nature (including, but not limited to, any notification, application, submission, or offer of a remedy or undertaking) with a Governmental Entity in respect of any Required Regulatory Approval and to give due consideration to any comments and suggestions received from the other Party, except that, with respect to an HSR Form, this provision shall apply only to Items 1 through 3 of each Party’s HSR Form, except that in the case of the notification under the HSR Act, the Parties need only exchange the first three pages of the notification and report form;

provide the other Party with final copies of any written communications of any nature with a Governmental Entity in respect of any Required Regulatory Approval, except that, with respect to an HSR Form, this provision shall apply only to Items 1 through 3 of each Party’s HSR Form; and

not participate in any meeting or discussion (whether in person, by phone or otherwise) with a Governmental Entity in respect of any Required Regulatory Approval unless it consults with the other Party in advance and gives the other Party the opportunity to attend thereat (except (a) where the timing of the response requested by the Governmental Entity does not reasonably permit such review, (b) the Governmental Entity expressly requests that the other Party should not be present at the meeting or discussion or part or parts of the meeting or discussion, or (c) where competitively or commercially sensitive information may

be discussed, in which case, with respect to meetings and discussions with the Governmental Entity, every effort will be made to allow external legal counsel to participate).

Where a Party (the “Supplying Party”) is required to supply any information in this Section 4.4 to the other Party (the “Receiving Party”) that the Supplying Party deems to be competitively or commercially sensitive information or otherwise reasonably determines in respect thereof that disclosure should be restricted, the Supplying Party may provide a redacted version removing the competitively or commercially sensitive information to the Receiving Party provided that the Supplying Party also provides a complete, non-redacted version to the Receiving Party’s external legal counsel on an external legal counsel only basis and the Receiving Party shall not request such competitively or commercially sensitive information from their external legal counsel; provided however that nothing in this Agreement requires any Party to share with another Party or its external legal counsel any information that relates to the valuation of the transactions contemplated by this Agreement or information relating to possible sale transactions with other Persons.

The Purchaser shall not, and shall cause its affiliates not to, take or agree to take any action, or assist, counsel or encourage any third party to take or agree to enter into any acquisition or other corporate transaction, whether directly or indirectly, after the date of this Agreement until the earlier of the termination of this Agreement or the Effective Date, that would be reasonably likely to (i) materially delay the obtaining of, or result in not obtaining, any permission, approval or consent from any Governmental Entity, including the Required Regulatory Approvals, necessary to be obtained prior to the Effective Date, (ii) materially increase the risk of any Governmental Entity entering an order prohibiting the consummation of the transactions contemplated by this Agreement, including the Arrangement, (iii) materially increase the risk of not being able to have vacated, lifted, reversed or overturned any such order on appeal or otherwise, or (iv) otherwise prevent or materially delay the consummation of the transactions contemplated by this Agreement, including the Arrangement.

The Purchaser shall, and shall cause its affiliates to, use commercially reasonable efforts to obtain and maintain the Required Regulatory Approvals as soon as practicable and in any event by no later than the Outside Date. For further clarity, the Purchaser’s commercially reasonable efforts shall not require the Purchaser to enter into any settlement, undertaking, consent, decree, stipulation or other agreement or take any action or agree to take any action with respect to any of the businesses or assets of the Purchaser or any of the businesses or assets of any of the Purchaser’s affiliates or that would, individually or in the aggregate and in the sole opinion of the Purchaser, acting reasonably, be likely to significantly and adversely affect the business or assets of the Company.

Each Party shall promptly notify the other Party if it becomes aware that any (i) application, filing, document or other submission for a Regulatory Approval contains a Misrepresentation, or (ii) any Regulatory Approval contains, reflects or was obtained following the submission of any application, filing, document or other submission

containing a Misrepresentation, such that an amendment or supplement may be necessary or advisable. In such case, the Parties will cooperate in the preparation, filing and dissemination, as applicable, of any such amendment or supplement.

As promptly as reasonably practicable after the date hereof, the Company shall and, where applicable, shall cause its affiliates and Subsidiaries to, use commercially reasonable efforts to obtain and maintain the Transportation Regulatory Approvals, and shall make all notifications, filings, applications and submissions with any Governmental Entity required or advisable in connection with the Transportation Regulatory Approvals.

The Purchaser shall use its commercially reasonable efforts to cooperate with the Company as reasonably necessary in connection with obtaining the Transportation Regulatory Approvals.

From the date hereof until the earlier of the Effective Time and the termination of this Agreement, subject to Law and the terms of any existing Contracts, the Company shall, and shall cause its Subsidiaries and their respective Representatives to, afford the Purchaser and its officers, employees, agents and representatives such access as the Purchaser may reasonably request at all reasonable times, including for the purpose of facilitating integration business planning, to their offices, properties, assets, books and records, Contracts, senior personnel or other information in respect of the Business, and shall make available to the Purchaser all financial data and other information as the Purchaser may reasonably request (including continuing access to the Data Room); provided that: (i) the Purchaser provides the Company with reasonable notice of any request under this Section 4.6(1); (ii) access to any materials contemplated in this Section 4.6(1) (other than the materials on the Data Room) shall be provided during the Company’s normal business hours only and in such manner not to interfere unreasonably with the conduct of the business of the Company or its Subsidiaries; and (iii) neither the Purchaser or any of its representatives shall contact officers or employees of the Company or any of its Subsidiaries except after prior approval of the Chief Financial Officer of the Company, which approval shall not be unreasonably withheld. Notwithstanding the foregoing, the Company shall not be obligated to provide access to, or to disclose, any information to the Purchaser if the Company reasonably determines that such access or disclosure would violate applicable Law, result in the disclosure of any trade secrets or similar information or violate any obligations of the Company or any other Person with respect to confidentiality, jeopardize any privilege claim by the Company or any of its Subsidiaries, interfere unreasonably with the conduct of the business of the Company or its Subsidiaries or require any action by the Company outside of normal business hours.

The Confidentiality Agreement shall continue to apply until the Effective Time, and any information provided under Section 4.6(1) is confidential and shall be subject to the terms of the Confidentiality Agreement.

For the purposes of this Section 4.7, “Transaction Personal Information” means the personal information (as defined by applicable privacy Laws) to be disclosed or conveyed to one Party or any of its representatives or agents (a “Recipient”) by or on behalf of another Party (a “Transferor”) as a result of or in conjunction with the Arrangement, and includes all such personal information disclosed to the Recipient prior to the execution of this Agreement.

Each Transferor acknowledges and confirms that the disclosure of Transaction Personal Information is necessary for the purposes of determining if the Parties shall proceed with the Arrangement and, if the determination is made to proceed with the Arrangement, to carry on the business and complete the Arrangement.

In addition to its other obligations hereunder, the Recipient covenants and agrees to: (i) prior to the completion of the Arrangement, collect, use and disclose the Transaction Personal Information solely for the purpose of reviewing and completing the Arrangement; (ii) protect and safeguard Transaction Personal Information against unauthorized collection, use or disclosure and in accordance with applicable privacy Laws; (iii) return or destroy the Transaction Personal Information, at the option of the Transferor, should the Arrangement not be completed; and (iv) if the Arrangement is completed, to use and disclose the Transaction Personal Information solely for the purposes for which such personal information was permitted to be used or disclosed by the Transferor prior to the completion of the Arrangement, to give effect to any withdrawal of consent to the collection, use and disclosure of Transaction Personal Information made by an individual, and to otherwise process such Transaction Personal Information in compliance with privacy Laws.

The Company shall use its reasonable best efforts, shall cause its Subsidiaries to use their reasonable best efforts to, provide such customary cooperation (including with respect to timeliness) to the Purchaser as the Purchaser may reasonably request in connection with the arrangements by the Purchaser to obtain the Debt Financing and Equity Financing, including any amendments, waivers and/or consents to the Company’s (or its Subsidiaries’) existing debt arrangements (provided that: (i) such request is made on reasonable notice; (ii) such cooperation does not unreasonably interfere with the ongoing business operations of the Company, its Subsidiaries or the Non-Controlled Entities; (iii) the Company shall not be required to provide, or cause any of its Subsidiaries to provide, cooperation that involves any binding commitment or agreement (including the entry into any agreement or the execution of any certificate) by the Company or its Subsidiaries (or commitment or agreement which becomes effective prior to the Effective Time) which is not conditional on the completion of the Arrangement and does not terminate without liability to the Company and its Subsidiaries upon the termination of this Agreement, and the Non-Controlled Entities will not be required to provide any such commitment in any case; (iv) neither the Company nor any of its Subsidiaries shall be required to take any action pursuant to any Contract, certificate or instrument that is not

contingent upon the occurrence of the Effective Time or that would be effective prior to the Effective Time; (v) neither the Board nor any of the Company’ Subsidiaries’ boards of directors (or equivalent bodies) shall be required to approve or adopt any Financing or Contracts related thereto (or any alternative financing) prior to the Effective Time (and no such directors that shall not be continuing directors shall be required to take such action); (vi) neither the Company nor any of its Subsidiaries shall be responsible for any adjustments to any pro forma financial information required to be provided in accordance with the Debt Commitment Letter; (vii) no employee, officer or director of the Company or its Subsidiary shall be required to take any action which would result in such Person incurring any personal liability (as opposed to liability in his or her capacity as an officer) with respect to any matters related to the Debt Financing; and (viii) any actions taken hereunder shall be, and shall deemed to be, taken in compliance with Section 4.1), including:

cooperating with the diligence efforts of the Purchaser and any Lender for all or any portion of the Debt Financing, in each case, upon reasonable notice and at mutually agreeable dates and times;

if requested by the Purchaser, furnishing the Purchaser and its proposed Lenders at least five Business Days prior to the Effective Date with all documentation and other information reasonably requested by the Lenders related to the Company, its Subsidiaries and the Non-Controlled Entities as required by any Lender with respect to the Debt Financing under applicable “know your customer” rules and regulations, including the PATRIOT Act (United States) to the extent requested at least eight Business Days prior to the closing of the Arrangement;

furnishing the Purchaser and its proposed Lenders, as applicable, as promptly as reasonably practicable, with the Financing Information and updating and correcting any Financing Information in order to ensure that such Financing Information satisfies the Compliance Requirements;

facilitating the removal of Liens by arranging for customary payoff letters, lien terminations and releases and instruments and acknowledgements of discharge (other than Liens on the property or assets of the Non- Controlled Entities), provided that no obligation of the Company, its Subsidiaries or the Non-Controlled Entities under any agreement shall be operative until the Effective Date;

assisting in preparation of appropriate and customary materials reasonably required in connection with the Debt Financing and participating in marketing efforts (including a reasonable number of meetings and calls) and a reasonable number of presentations, drafting sessions, due diligence sessions (including accounting due diligence sessions), and sessions with prospective lenders and investors and commitment parties and purchasers, in each case at reasonable times and locations mutually agreed;

using commercially reasonable efforts to obtain from the Company’s accounting firm accountants’, consistent with customary practice, customary comfort letters and consents customary for financings similar to the Debt Financing, and providing customary information and assistance reasonably necessary to assist the Purchaser and its counsel with obtaining the customary legal opinions required to be delivered in connection with the Debt Financing;

executing and delivering (or assisting in the execution and delivery of), as of the completion of the Arrangement, any pledge and security documents, other definitive financing documents or other certificates (including, but not limited to a solvency certificate of the chief financial officer and factual back-up certificates for legal opinions) or documents as may be reasonably requested by the Purchaser and otherwise facilitating the pledging of collateral (including cooperation in connection with the pay-off of existing indebtedness to the extent contemplated by this Agreement and the release of related Liens and termination of security interests);

preventing the offer, placement or arrangement of any debt securities or syndicated credit facilities by or on behalf of the Company or any of its Subsidiaries (except as permitted by this Agreement).

Notwithstanding Section 4.8(1), none the Company or any of its Subsidiaries shall be required to: (i) pay any commitment, consent or other similar fee, incur any liability, or provide or agree to provide any indemnity in connection with any such financing prior to the Effective Time; (ii) take any action or do anything that would: (a) contravene any applicable Law or its organizational or constating documents; (b) contravene any of the Company’s, any of its Subsidiaries’ or the Non-Controlled Entities’ agreements that relate to borrowed money or any Contract; (c) be capable of impairing or preventing the satisfaction of any condition set forth in Article 6; (d) cause any breach of this Agreement that would provide the Purchaser with the right to terminate this Agreement or seek indemnity, reimbursement of expenses or the payment of the Termination Fee under the terms hereof; (iii) disclose any information that in the reasonable judgment of the Company would result in the disclosure of any trade secrets or similar information or violate any obligations of the Company or any other Person with respect to confidentiality; or (iv) waive or amend any terms of this Agreement. Nothing in this Agreement will require any Representative of the Company or any of its Subsidiaries to deliver any certificate or opinion or take any other action pursuant to this Section 4.8 or any other provision of Section 4.8(1) that would or would reasonably be expected to result in personal liability to such Representative.

The Purchaser shall, promptly upon request by the Company (and in any event following termination of this Agreement), reimburse the Company, its Subsidiaries and the Non- Controlled Entities for all reasonable and documented out-of-pocket costs (including reasonable and documented out-of-pocket legal fees) incurred by the Company, its Subsidiaries or the Non-Controlled Entities in connection with any of the actions contemplated by this Section 4.8, and shall indemnify and hold harmless the Company,

its Subsidiaries, the Non-Controlled Entities and their respective Representatives from and against any and all losses, damages, claims, costs or expenses suffered or incurred by any of them in connection with the cooperation of the Company and its Subsidiaries contemplated by this Section 4.8 or in connection with Financings.

The Company hereby consents to the use of its and its Subsidiaries’ trademarks, trade names and logos in connection with the Debt Financing; provided, that such trademarks, trade names and logos are used solely (i) in a manner that is not intended, or reasonably likely, to harm or disparage the Company or its Subsidiaries or the reputation or goodwill of the Company or its Subsidiaries and (ii) solely in connection with a description of the Company, its business and products or the transactions contemplated by this Agreement (including the Debt Financing).

Prior to the Effective Time, the Company shall, in reasonable consultation with the Purchaser, (and, if the Company is unable to, the Purchaser shall cause the Company as of the Effective Time to) obtain from an insurance carrier with the same or better credit rating as the Company’s current insurance carriers with respect to directors’ and officers’ liability insurance, and fully pay a single premium for, customary “tail” policies of directors’ and officers’ liability insurance providing protection for a claims reporting or discovery period beginning at the Effective Time and continuing for not less than six years from and after the Effective Time and with terms, conditions, retentions and limits of liability that are no less favourable to the directors and officers in the aggregate than

the protection provided by the policies maintained by the Company which are in effect immediately prior to the Effective Date and providing protection in respect of claims arising from facts or events which occurred on or prior to the Effective Date provided that the cost of such policies shall not exceed 300% of the annual premiums for the Company’s directors and officers insurance in effect as of the date of this Agreement.

From and after the Effective Time, the Purchaser shall, and shall cause the Company to, indemnify and hold harmless, to the fullest extent permitted under applicable Law (and to also advance expenses as incurred to the fullest extent permitted under applicable Law), each present and former director and officer of the Company and its Subsidiaries and each present and former designate or nominee of the Company or its Subsidiaries on the board of directors (or equivalent body) of the Non-Controlled Entities (each, an “Indemnified Person”) against any costs or expenses (including reasonable attorneys’ fees), judgments, fines, losses, claims, damages or liabilities incurred in connection with any Proceeding arising out of or related to such Indemnified Person’s service as a director or officer of the Company, any of its Subsidiaries and/or any of the Non-Controlled Entities or services performed by such persons at the request of the Company, any of its Subsidiaries or any of the Non-Controlled Entities at or prior to or following the Effective Time, whether asserted or claimed prior to, at or after the Effective Time, including the approval or completion of this Agreement and the Arrangement or any of the other transactions contemplated by this Agreement or arising out of or related to this Agreement and the transactions contemplated hereby. None of the Purchaser, the Company or any of their respective Subsidiaries shall, and they will use commercially reasonable efforts to ensure that no Non-Controlled Entity shall, settle, compromise or consent to the entry of any judgment in any Proceeding involving or naming an Indemnified Person or arising out of or related to an Indemnified Person’s service as a director or officer of the Company, any of its Subsidiaries and/or any of the Non- Controlled Entities or services performed by such Indemnified Person at the request of the Company, any of its Subsidiaries or any of the Non-Controlled Entities at or prior to or following the Effective Time without the prior written consent (not to be unreasonably withheld or delayed) of that Indemnified Person, unless such settlement, compromise or consent includes an unconditional release of such Indemnified Person from all liability arising out of such Proceeding.

The Purchaser shall, and shall use commercially reasonable efforts to cause the Non-Controlled Entities to from and after the Effective Time, honour all rights to indemnification or exculpation now existing in favour of present and former employees, officers and directors of the Company and its Subsidiaries and the Company’s and its Subsidiaries’ designates, nominees and appointees as officers and directors of the Non-Controlled Entities and acknowledges that such rights shall survive the completion of the Plan of Arrangement and shall continue in full force and effect in accordance with their terms for a period of not less than six years from the Effective Date.

If any Indemnified Person makes any claim for indemnification or advancement of expenses under this Section 4.10 that is denied by the Company or the Purchaser, and a court of competent jurisdiction determines that the Indemnified Person is entitled to such indemnification, then the Company and the Purchaser shall pay such Indemnified

Person’s costs and expenses, including reasonable legal fees and expenses, incurred in connection with pursuing such claim against the Company or the Purchaser.

The rights of the Indemnified Persons under this Section 4.10 shall be in addition to any rights such Indemnified Persons may have under the Company Constating Documents or the constating documents of any of its Subsidiaries and the Non-Controlled Entities, or under any applicable Law or agreement of any Indemnified Person with the Company, any of its Subsidiaries or any of the Non-Controlled Entities. All rights to indemnification and exculpation from liabilities for acts or omissions occurring at or prior to the Effective Time and rights to advancement of expenses relating thereto in favour of any Indemnified Person as provided in the constating documents of the Company, any of its Subsidiaries or any of the Non-Controlled Entities or any agreement between such Indemnified Person and the Company, any of its Subsidiaries or any of the Non-Controlled Entities shall survive the Effective Time for a period of not less than six years and shall not be amended, repealed or otherwise modified in any manner that would adversely affect any right thereunder of any such Indemnified Person.

If any of the Company, the Purchaser or any of their successors or assigns shall (i) amalgamate, consolidate with or merge or wind-up into any other person and shall not be the continuing or surviving corporation or entity, or (ii) transfer all or substantially all of its properties and assets to any person, then, and in each such case, proper provisions shall be made so that the successors and assigns and transferees of the Company or the Purchaser, as the case may be, shall assume all of the obligations set forth in this Section 4.10. The Purchaser shall ensure that it, the Company, and any of their successors or assigns have adequate financial resources to satisfy all of the obligations set forth in this Section 4.10.

The Company agrees that, upon the reasonable request by the Purchaser, the Company shall use commercially reasonable efforts to: (i) effect such reorganizations of the Company’s corporate structure, capital structure, business, operations and assets or such other transactions as the Purchaser may request, acting reasonably (each a “Pre-Acquisition Reorganization”); and (ii) co-operate with the Purchaser and its advisors in order to determine the nature of any Pre-Acquisition Reorganization that might be undertaken and the manner in which any Pre-Acquisition Reorganization might most effectively be undertaken; provided that any Pre-Acquisition Reorganization: (a) is not prejudicial to the Company or the Company Securityholders in any material respect; (b) does not require the Company to obtain the approval of any of the Company Securityholders and does not require the Company or any of its Subsidiaries to obtain the consent of any third party (including under any Authorization); (c) does not impair, prevent or delay the consummation of the Arrangement or the ability of the Purchaser to obtain any financing required by it in connection with the transactions contemplated by this Agreement (including the Financings); (d) is effected as closely as is reasonably practicable to the Effective Time; (e) does not result in any breach by the Company or any of its Subsidiaries of any Contract, Authorization, organizational documents or Law; and (f) does not result in Taxes being imposed on, or any adverse Tax or other

consequences to, any Company Securityholder. The Purchaser hereby waives any breach of a representation, warranty or covenant by the Company, where such breach is a result of an action taken by the Company or a Subsidiary pursuant to a request by the Purchaser in accordance with this Section 4.11. The Purchaser shall provide written notice to the Company of any proposed Pre-Acquisition Reorganization at least ten Business Days prior to the Effective Time. Upon receipt of such notice, the Purchaser and the Company shall work co-operatively and use commercially reasonable efforts to prepare prior to the Effective Time all documentation necessary and do all such other acts and things as are reasonably necessary, including making amendments to this Agreement or the Plan of Arrangement (provided that such amendments do not require the Company to obtain approval of the Company Securityholders (other than as properly put forward and approved at the Company Meeting)), to give effect to such Pre-Acquisition Reorganization. If the Arrangement is not completed, the Purchaser (x) shall forthwith reimburse the Company for all costs and expenses, including legal fees and disbursements, incurred by the Company and its Subsidiaries in connection with any proposed Pre-Acquisition Reorganization or otherwise pursuant to this Section 4.11; and (y) hereby indemnifies and holds harmless the Company, its Subsidiaries and their respective Representatives from and against any and all liabilities, losses, damages, costs and Taxes suffered or incurred by any of them in connection with or as a result of any Pre-Acquisition Reorganization or otherwise pursuant to this Section 4.11, or to reverse or unwind any Pre-Acquisition Reorganization or other steps taken pursuant to this Section 4.11.

Without limiting the generality of the foregoing, the Company acknowledges that the Purchaser may enter into one or more transactions (the “Bump Transactions”) designed to step up the adjusted cost base of certain non-depreciable capital property of the Company or its Subsidiaries for purposes of the Tax Act and agrees to use commercially reasonable efforts to provide information reasonably required by the Purchaser in this regard on a timely basis and to assist in the obtaining of any such information in order to facilitate a successful completion of the Bump Transactions or any such other reorganizations or transactions as is reasonably requested by the Purchaser.

as promptly as possible after the date hereof, the Company shall provide the Purchaser with a list of all material Tax Returns with respect to which the Company or any of its Subsidiaries has requested an extension of time within which to file such Tax Return which Tax Return has not yet been filed; and

until the Effective Date the Company and its Subsidiaries will (i) duly and timely file with the appropriate Governmental Entity all Tax Returns required to be filed by any of them, which shall be correct and complete in all respects, and (ii) pay, withhold, collect and remit to the appropriate Governmental Entity in a timely fashion all amounts required to be so paid, withheld, collected or remitted. The Company shall keep the Purchaser reasonably informed of any events, discussions, notices or changes with respect to any

Tax or regulatory investigation or any other investigation by a Governmental Entity or Proceeding involving the Company or any of its Subsidiaries (other than ordinary course communications which could not reasonably be expected to be material to the Corporation, its Subsidiaries or its business).

Except as provided in this Article 5, the Company and its Subsidiaries shall not, directly or indirectly, through any officer, director, employee, representative (including any financial or other advisor) or agent of the Company or of any of its Subsidiaries (collectively, “Representatives”):

solicit, assist, initiate, encourage or otherwise facilitate (including by way of furnishing or providing copies of, access to, or disclosure of, any confidential information, properties, facilities, books or records of the Company or any of its Subsidiaries or entering into any form of agreement, arrangement or understanding) any inquiry, proposal or offer that constitutes, or would reasonably be expected to constitute or lead to, an Acquisition Proposal;

continue, enter into or otherwise engage or participate in any discussions or negotiations with any Person (other than the Purchaser) regarding any Acquisition Proposal, provided that the Company may (a) communicate with any Person for the purposes of clarifying the terms of any inquiry, proposal or offer made by such Person that constitutes or could reasonably be expected to constitute or lead to, an Acquisition Proposal, (b) advise any Person of the restrictions of this Agreement, and (c) advise any Person making an Acquisition Proposal that the Board has determined that such Acquisition Proposal does not constitute a Superior Proposal;

publicly withdraw, amend, modify or qualify in a manner adverse to the Purchaser, or publicly propose to withdraw, amend, modify or qualify in a manner adverse to the Purchaser the Board Recommendation (it being understood that publicly taking no position or a neutral position with respect to a publicly announced, or otherwise publicly disclosed, Acquisition Proposal for a period of no more than five Business Days following the announcement of the Acquisition Proposal will not be considered to be in violation of this Section 5.1, provided the

Board has rejected such Acquisition Proposal and affirmed the Board Recommendation before the end of such five Business Day period);

accept, approve, endorse or recommend, or publicly propose, to accept, approve, endorse or recommend any Acquisition Proposal (it being understood that publicly taking no position or a neutral position with respect to a publicly announced, or otherwise publicly disclosed, Acquisition Proposal for a period of no more than five Business Days following the announcement of the Acquisition Proposal will not be considered to be in violation of this Section 5.1, provided the Board has rejected such Acquisition Proposal and affirmed the Board Recommendation before the end of such five Business Day period); or

accept, approve, endorse, recommend or execute or enter into or publicly propose to accept, approve, endorse, recommend or execute or enter into any agreement, letter of intent, understanding or arrangement in respect of an Acquisition Proposal (other than a confidentiality agreement permitted by and in accordance with Section 5.3).

The Company shall, and shall cause its Subsidiaries and its and their Representatives to, immediately cease and terminate, and cause to be terminated, any solicitation, encouragement, discussion, negotiation or other activities commenced prior to the date of this Agreement with any Person (other than the Purchaser and the Equity Investors) with respect to any inquiry, proposal or offer that constitutes, or would reasonably be expected to constitute or lead to, an Acquisition Proposal, and in connection therewith, the Company will:

immediately discontinue access to, and disclosure of, all of its confidential information (including through any data room or through granting access to any books and records or its properties or facilities); and

within two Business Days of the date hereof, request, and exercise all rights it has to require, (a) the return or destruction of all copies of any confidential information regarding the Company or any of its Subsidiaries provided to any such Person, and (b) the destruction of all material including or incorporating or otherwise reflecting such confidential information regarding the Company or any of its Subsidiaries provided to any such Person in each case using its commercially reasonable efforts to ensure that such requests are fully complied with in accordance with the terms of such rights or entitlements.

The Company covenants and agrees that (i) it shall take all commercially reasonable action necessary to enforce each confidentiality, standstill or similar agreement, restriction or covenant to which it or any of its Subsidiaries is a party, and (ii) neither it, nor any of its Subsidiaries or any of their respective Representatives have or will, without the prior written consent of the Purchaser (which may be withheld or delayed in the Purchaser’s sole and absolute discretion), release any Person from, or waive, amend, suspend or otherwise modify such Person’s obligations respecting the Company or any of its Subsidiaries under any confidentiality, standstill or similar agreement, restriction or

covenant to which the Company or any of its Subsidiaries is a party (it being acknowledged by the Purchaser that the automatic termination or release of any standstill restrictions as a result of entering into and announcing this Agreement or otherwise in accordance with such restrictions shall not be a violation of this Section 5.1(3)).

If at any time prior to the approval of the Arrangement Resolution in accordance with the Interim Order, the Company receives a bona fide written Acquisition Proposal from a Person, the Company and its Representatives may enter into, engage in, participate in, facilitate and maintain discussions or negotiations with, and otherwise co-operate with or assist, such Person regarding such Acquisition Proposal, and may provide copies of, access to or disclosure of any information, properties, facilities, books or records of the Company and its Subsidiaries to such Person, if and only if:

the Board first determines in good faith, after consultation with its financial advisors and its outside legal counsel, that such Acquisition Proposal constitutes or could reasonably be expected to constitute or lead to a Superior Proposal;

such Acquisition Proposal did not result from a breach by the Company of its obligations under this Article 5;

such Person was not restricted from making such Acquisition Proposal pursuant to an existing standstill or similar restriction;

prior to providing any such copies, access or disclosure, (a) the Company enters into a confidentiality agreement with such Person on terms that are no less favourable to the Company than those of the Confidentiality Agreement, and (b) any such copies, access or disclosure (other than verbal disclosure) provided

to such Person shall have already been (or shall simultaneously be) provided to the Purchaser; and

prior to providing any such copies, access or disclosure to such Person, the Company provides the Purchaser with a true, complete and final executed copy of the confidentiality agreement referred to in Section 5.3(1)(iv).

Nothing contained in this Agreement shall prohibit the Board or the Company from making any disclosure to the Company Securityholders (i) if the Board, acting in good faith and upon the advice of its legal advisors, shall have first determined that the failure to make such disclosure would be inconsistent with the fiduciary duties of the Board or such disclosure is otherwise required under applicable Law or (ii) or as required by applicable Law, including in response to an Acquisition Proposal (including by responding to an Acquisition Proposal in a directors’ circular); provided that, notwithstanding that the Board or the Company shall be permitted to make such disclosure, the Board shall not be permitted to make a Change in Recommendation, other than as permitted by Section 5.4(1). Nothing contained in this Agreement shall prohibit the Company or the Board from calling and/or holding a meeting of Common Shareholders requisitioned by Common Shareholders in accordance with the OBCA or taking any other action to the extent ordered or otherwise mandated by a Governmental Entity in accordance with applicable Laws.

If the Company receives an Acquisition Proposal that the Board determines, in good faith, constitutes a Superior Proposal prior to the approval of the Arrangement Resolution in accordance with the Interim Order, the Board may, subject to compliance with Article 7 and Section 8.2, authorize the Company to enter into a definitive agreement with respect to such Superior Proposal or may make a Change in Recommendation, if and only if:

the Person making the Superior Proposal was not restricted from making such Superior Proposal pursuant to an existing standstill or similar restriction;

such Acquisition Proposal did not result from a breach by the Company of its obligations under this Article 5;

the Company has delivered to the Purchaser a written notice of the determination of the Board that such Acquisition Proposal constitutes a Superior Proposal and of the intention of the Board to enter into such definitive agreement with respect to such Acquisition Proposal or to make a Change in Recommendation (a “Superior Proposal Notice”);

the Company has provided the Purchaser with a copy of the proposed definitive agreement for the Superior Proposal (if any) and all supporting materials supplied to the Company in connection therewith, including the value in financial terms that the Board has, with its financial advisors, determined should be ascribed to any non-cash consideration offered under the Superior Proposal;

at least five Business Days have elapsed from the date that is the later of the date on which the Purchaser received the Superior Proposal Notice and the date on which the Purchaser received all of the materials set forth in Section 5.4(1)(iv) (the “Matching Period”);

after the Matching Period, the Board has determined in good faith, after consultation with its outside legal counsel and financial advisors, that such Acquisition Proposal continues to constitute a Superior Proposal (if applicable, compared to the terms of the Arrangement as proposed to be amended by the Purchaser under Section 5.4(2)); and

prior to or concurrently with entering into such definitive agreement the Company terminates this Agreement pursuant to Section 7.2(1)(iii)(b) and pays the Termination Fee pursuant to Section 8.2.

During the Matching Period, or such longer period as the Company may approve in writing for such purpose: (i) the Purchaser shall have the opportunity (but not the obligation), to offer to amend this Agreement and the Arrangement in order for such Acquisition Proposal to cease to be a Superior Proposal; (ii) the Board shall review any offer made by the Purchaser to amend the terms of this Agreement and the Arrangement, in consultation with outside legal and financial advisors and in good faith, to determine whether such proposal would, upon acceptance, result in the Acquisition Proposal previously determined to constitute a Superior Proposal ceasing to be a Superior Proposal; and (iii) if the Board determines that such Acquisition Proposal would no longer constitute a Superior Proposal, the Company shall negotiate in good faith with the Purchaser to make such amendments to the terms of this Agreement and the Arrangement as would enable the Purchaser to proceed with the transactions contemplated by this Agreement on such amended terms.

Each successive amendment or modification to any Acquisition Proposal that results in an increase in, or modification of, the consideration (or value of such consideration) to be received by the Company Securityholders or other material terms or conditions thereof shall constitute a new Acquisition Proposal for the purposes of this Section 5.4 and the Purchaser shall be afforded a new Matching Period in connection therewith, provided that, notwithstanding Section 5.4(1)(v) above, the duration of such Matching Period shall be three Business Days rather than five Business Days.

The Board shall promptly reaffirm the Board Recommendation by press release after any Acquisition Proposal that is determined not to be a Superior Proposal if the Board determines that a proposed amendment to the terms of this Agreement as contemplated under Section 5.4(2) would result in an Acquisition Proposal no longer being a Superior Proposal. The Company shall provide the Purchaser and its legal counsel the reasonable opportunity to review the form and content of any such press release and shall make all reasonable amendments to such press release as requested by the Purchaser and its legal counsel.

If the Company provides a Superior Proposal Notice to the Purchaser on a date that is less than ten Business Days before the Company Meeting, the Company shall be entitled to, and the Purchaser shall be entitled to require the Company to, adjourn or postpone the Company Meeting to a date that is not more than ten Business Days after the date of the Superior Proposal Notice; provided, however, that the Company Meeting shall not be adjourned or postponed to a date later than the seventh Business Day prior to the Outside Date.

Any violation of the restrictions set forth in this Article 5 by the Company, its Subsidiaries or their respective Representatives shall be deemed to be a breach of this Article 5 by the Company.

Arrangement Resolution. The Arrangement Resolution has been approved and adopted at the Company Meeting in accordance with the Interim Order.

Interim Order and Final Order. The Interim Order and the Final Order have each been obtained on terms consistent with this Agreement and have not been set aside or modified in a manner unacceptable to either the Company or the Purchaser, each acting reasonably, on appeal or otherwise.

Articles of Arrangement. The Articles of Arrangement to be sent to the Director under the OBCA in accordance with this Agreement shall be in a form and content satisfactory to the Company and the Purchaser, each acting reasonably.

No Restraint. No Law, judgment, order, writ, injunction or decree of any Governmental Entity (collectively, “Restraints”) is in effect that makes the consummation of the Arrangement illegal or enjoins or otherwise prohibits the Company or the Purchaser from consummating the Arrangement.

Required Regulatory Approvals. Each of the Required Regulatory Approvals has been obtained.

Representations and Warranties. The representations and warranties of the Company set forth in (i) Paragraph (1) [Organization and Qualification], Paragraph (2) [Authorization], Paragraph (4) [Execution and Binding Obligation] of Schedule D hereto shall be true and correct in all material respects as of the Effective Date as if made at and as of the Effective Date (except, in each case, for representations and warranties made as of a specified date, the accuracy of which shall be determined as of such specified date); (ii) Paragraph (3) [Capitalization] (other than Paragraph (3)(e)) and Paragraph (8)(e) of Schedule D hereto and shall be true and correct in all respects (other than de minimis inaccuracies) as of the Effective Time as if made at and as of the Effective Time (except, in each case, for representations and warranties made as of a specified date, the accuracy of which shall be determined as of such specified date); and (iii) this Agreement (including in Schedule D hereto, other than those to which clause (i) or (ii) above applies) shall be true and correct as of the Effective Time as if made at and as of the Effective Time (except, in each case, for representations and warranties made as of a specified date, the accuracy of which shall be determined as of such specified date), except in the case of this clause (iii) to the extent that the failure or failures of such representations and warranties to be so true and correct, individually or in the aggregate, would not have a Material Adverse Effect (and, for the purpose of this clause (iii), any reference to “material”, “Material Adverse Effect” or other concept of materiality in such representations and warranties shall be ignored); and the Company shall have delivered to the Purchaser a certificate addressed to the Purchaser, dated the Effective Date and executed by two of its senior officers (without personal liability), confirming the same.

Performance of Covenants. The Company shall have fulfilled or complied in all material respects with each of the covenants of the Company contained in this Agreement to be fulfilled or complied with by it on or prior to the Effective Time, and the Company shall have delivered to the Purchaser a certificate addressed to the Purchaser, dated the Effective Date and executed by two of its senior officers (without personal liability), confirming same.

No Actions. No action or proceeding has been taken by any Governmental Entity (as described in clause (i) of the definition of Governmental Entity) against the Company or that Purchaser that would:

cease trade, enjoin, prohibit or impose any limitations on the Purchaser’s ability to acquire, hold, or exercise full right of ownership over, any Common Shares, including the right to vote the Common Shares, upon completion of the Arrangement; or

prohibit the ownership or operation by Purchaser of the business of the Company or any of the Company’s Subsidiaries or any material portion of the business or assets of the Company or any of the Company’s Subsidiaries’ as a result of the Arrangement.

Material Adverse Effect. Since the date of this Agreement there shall not have been or occurred a Material Adverse Effect.

Dissent. Dissent Rights shall not have been validly exercised, and not withdrawn or deemed to have been withdrawn, in respect of more than 5% of the outstanding Common Shares held by the Common Shareholders.

Borrowings under Existing Credit Facilities. The aggregate outstanding principal amount of indebtedness for borrowed money outstanding under the Existing Credit Facilities as of the Effective Date shall not exceed $250,000,000. The Parties acknowledge and agree that the condition contemplated by this Section 6.2(6) has been included in this Agreement because the aggregate amounts to be made available to the Purchaser under the Debt Commitment Letter and the Equity Commitment Letter would be insufficient to fund the amounts contemplated by Section 2.10 if the condition contemplated by this Section 6.2(6) is not satisfied. Accordingly, if all the other conditions to closing contemplated by Section 6.1, Section 6.2 and Section 6.3 have been satisfied or waived (excluding conditions that, by their terms, are to be satisfied on the Effective Date), then the Parties shall cooperate in good faith with each other and use commercially reasonable efforts to arrange for additional debt financing (either from the Lenders or from an alternative lender or lenders) on terms no less favourable to the Purchaser than those contained in the Debt Commitment Letter such that the Purchaser would have sufficient funds to consummate the Arrangement and, in the event that such additional debt financing can be arranged on such terms, the condition in this Section 6.2(6) shall then be deemed to be satisfied.

Representations and Warranties. The representations and warranties of the Purchaser set forth in this Agreement (including in Schedule E) are true and correct as of the Effective Time, as if made at and as of the Effective Time (except, in each case, for representations and warranties made as of a specified date, the accuracy of which shall be determined as of such specified date), except to the extent that the failure or failures of such representations and warranties to be so true and correct, individually or in the aggregate, would not materially impede the completion of the Arrangement, and the Purchaser shall have delivered to the Company a certificate addressed to the Company, dated the Effective Date and executed by two of its senior officers (without personal liability), confirming same.

Performance of Covenants. The Purchaser shall have fulfilled or complied in all material respects with each of its covenants contained in this Agreement to be fulfilled or complied with by them on or prior to the Effective Time, and the Purchaser shall have delivered to the Company a certificate addressed to the Company, dated the Effective Date and executed by two of its senior officers (without personal liability), confirming same.

Payment of Consideration. The Purchaser shall have deposited, or caused to be deposited, with the Depositary sufficient funds to satisfy the obligations under Section 2.10 and the Depositary will have confirmed to the Company receipt from or on behalf of the Purchaser of the funds contemplated by Section 2.10.

This Agreement may be terminated and the Arrangement abandoned at any time prior to the Effective Time (notwithstanding approval of the Arrangement Resolution and/or receipt of the Final Order) by:

the mutual written agreement of the Parties; or

the Company or the Purchaser, if:

the Arrangement Resolution is not approved by the Common Shareholders entitled to vote thereon at the Company Meeting in accordance with the Interim Order; or

after the date of this Agreement, any Restraint is enacted, made, enforced or amended, as applicable, that has the effect set forth in Section 6.1(4) and such Restraint has become final and non-appealable; provided that the Party seeking to terminate this Agreement pursuant to this Section 7.2(1)(ii)(b) shall have used commercially reasonable efforts to prevent, appeal or overturn such Restraint or otherwise have it lifted or rendered non-applicable in respect of the Arrangement and provided further that the enactment, making, enforcement or amendment of such Restraint was not primarily due to the fault of such Party to perform any of its covenants or agreements under this Agreement; or

the Effective Time does not occur on or prior to the Outside Date, provided that a Party may not terminate this Agreement pursuant to this Section 7.2(1)(ii)(c) if the failure of the Effective Time to so occur has been caused by, or is a result of, a breach by such Party of any of its representations or warranties or the failure of such Party to perform any of its covenants or agreements under this Agreement; or

the Company if:

a breach of any representation or warranty or failure to perform any covenant or agreement on the part of the Purchaser under this Agreement occurs that would cause any condition in Section 6.3(1) [Purchaser Representations and Warranties Condition] or Section 6.3(2) [Purchaser Covenants Condition] not to be satisfied, and such breach or failure is incapable of being cured or is not cured in accordance with the terms of Section 7.3; provided that the Company is not then in breach of this Agreement so as to cause any condition in Section 6.2(1) [Company Representations and Warranties Condition] or Section 6.2(2) [Company Covenants Condition] not to be satisfied; or

prior to the approval of the Arrangement Resolution in accordance with the Interim Order, the Board authorizes the Company, subject to complying with the terms of this Agreement (including the terms of Article 5 and payment of the Termination Fee in accordance with Section 8.2) to enter into a definitive written agreement (other than a confidentiality agreement permitted by and in accordance with Section 5.3) with respect to a Superior Proposal; or

after the Marketing Period has ended, (A) all conditions in Section 6.1 [Mutual Conditions Precedent] and Section 6.2 [Purchaser Conditions Precedent] (excluding conditions that, by their terms, are to be satisfied on the Effective Date) have been satisfied or waived, (B) the Company has irrevocably given notice to the Purchaser in writing that it is ready, willing, and able to complete the Arrangement, (C) the Company has given the Purchaser written notice at least five (5) Business Days prior to such termination stating the Company’s intention to terminate this Agreement pursuant to this Section 7.2(1)(iii)(c), and (D) the Purchaser does not provide or cause to be provided the Depositary with sufficient funds to purchase the Common Shares contemplated by the Agreement as required pursuant to Section 2.10 within five (5) Business Days after the delivery of such notice; or

the Purchaser, if:

a breach of any representation or warranty or failure to perform any covenant or agreement on the part of the Company under this Agreement occurs that would cause any condition in Section 6.2(1) [Company

Representations and Warranties Condition] or Section 6.2(2) [Company Covenants Condition] not to be satisfied, and such breach or failure is incapable of being cured or is not cured in accordance with the terms of Section 7.3; provided that the Purchaser is not then in breach of this Agreement so as to cause any condition in Section 6.3(1) [Purchaser Representations and Warranties Condition] or Section 6.3(2) [Purchaser Covenants Condition] not to be satisfied; or

(A) the Board fails to recommend, or publicly withdraws, amends, modifies or qualifies in a manner adverse to the Purchaser Proposal, or publicly proposes to withdraw, amend, modify or qualify in a manner adverse to the Purchaser, the Board Recommendation (it being understood that publicly taking no position or a neutral position with respect to a publicly announced, or otherwise publicly disclosed, Acquisition Proposal for a period of no more than five Business Days will not be considered to be an adverse withdrawal, amendment, modification or qualification, provided the Board has rejected such Acquisition Proposal and affirmed the Board Recommendation before the end of such five Business Day period), unless the Purchaser shall have breached a covenant or representation or warranty under this Agreement in such a manner that the Company would be entitled to terminate this Agreement in accordance with Section 7.2(1)(ii)(c) or Section 7.2(1)(iii)(a), (B) the Board accepts, approves, endorses or recommends, or publicly proposes to accept, approve, endorse or recommend, an Acquisition Proposal (it being understood that publicly taking no position or a neutral position with respect to a publicly announced, or otherwise publicly disclosed, Acquisition Proposal for a period of no more than five Business Days will not be considered to be an acceptance, approval, endorsement or recommendation of such Acquisition Proposal, provided the Board has rejected such Acquisition Proposal and affirmed the Board Recommendation before the end of such five Business Day period), unless the Purchaser shall have breached a covenant or representation or warranty under this Agreement in such a manner that the Company would be entitled to terminate this Agreement in accordance with Section 7.2(1)(ii)(c) or Section 7.2(1)(iii)(a), or (C) the Board enters into or publicly proposes to accept or enter into any written agreement, understanding or arrangement in respect of an Acquisition Proposal (other than a confidentiality agreement permitted by and in accordance with Section 5.3) (any action set forth in clauses (A) or (B), a “Change in Recommendation”).

Subject to Section 7.3(3), if applicable, the Party desiring to terminate this Agreement pursuant to this Section 7.2 (other than pursuant to Section 7.2(1)(i)) shall give notice of such termination to the other Party, specifying in reasonable detail the basis for such Party’s exercise of its termination right.

Each Party shall promptly notify the other Party of the occurrence, or failure to occur, at any time from the date hereof until the earlier to occur of (i) the termination of this Agreement in accordance with its terms and (ii) the Effective Time, of any event or state of facts which occurrence or failure would, or would be reasonably likely to:

cause any of the representations or warranties of any Party contained in this Agreement to be untrue or inaccurate in any material respect at any time from the date of this Agreement to the Effective Time (provided that this Section 7.3(1)(ii)(a) shall not apply in the case of any event or state of facts resulting from the actions or omissions of another Party which are required under this Agreement); or

result in the failure to comply with or satisfy any covenant, condition or agreement to be complied with or satisfied by any Party under this Agreement.

Notification provided under this Section 7.3 will not affect the representations, warranties, covenants, agreements or obligations of the Parties (or remedies with respect thereto) or the conditions to the obligations of the Parties under this Agreement.

The Company may not elect to exercise its right to terminate this Agreement pursuant to Section 7.2(1)(iii)(a) and the Purchaser may not elect to exercise its right to terminate this Agreement pursuant to Section 7.2(1)(iv)(a), unless the Party seeking to terminate this Agreement (the “Terminating Party”) has delivered a written notice (“Termination Notice”) to the other Party (the “Breaching Party”) specifying in reasonable detail all breaches of covenants, representations and warranties or other matters which the Terminating Party asserts as the basis for termination. After delivering a Termination Notice, provided the Breaching Party is proceeding diligently to cure such matter and such matter is capable of being cured prior to the Outside Date, the Terminating Party may not exercise such termination right until the earlier of (i) the Outside Date, and (ii) if the breach is capable of being cured prior to the Outside Date, the date that is 30 days following receipt of such Termination Notice by the Breaching Party, if the Breaching Party shall not have commenced good faith efforts to cure the applicable breach. If the Terminating Party delivers a Termination Notice prior to the date of the Company Meeting, unless the Parties agree otherwise, the Company may adjourn or postpone the Company Meeting to the earlier of (a) seven Business Days prior to the Outside Date, and (b) the date that is 20 Business Days following receipt of such Termination Notice by the Breaching Party (without causing any breach of any other provision contained herein).

This Agreement and the Plan of Arrangement may, at any time and from time to time before or after the holding of the Company Meeting but not later than the Effective Time, be amended by mutual written agreement of the Parties, without further notice to or authorization on the part of the Common Shareholders, and any such amendment may, subject to the Interim Order and Final Order and Laws, without limitation:

change the time for performance of any of the obligations or acts of the Parties;

modify any representation or warranty contained in this Agreement or in any document delivered pursuant to this Agreement;

modify any of the covenants contained in this Agreement and waive or modify performance of any of the obligations of the Parties; and/or

modify any mutual conditions contained in this Agreement.

Notwithstanding anything to the contrary contained herein, this Section 8.1, Section 8.2(11), Section 8.7 and Section 8.12(3), (4) and (5) and Section 8.17 may not be amended, supplemented, waived or otherwise modified in a manner adverse to the financial institutions identified in the Debt Commitment Letter (or any Debt Financing Sources related thereto) without the prior written consent of such financial institutions.

Except as otherwise provided herein, all fees, costs and expenses incurred in connection with this Agreement and the Plan of Arrangement shall be paid by the Party and its affiliates and representatives incurring such costs or expenses and the Purchaser shall be responsible for any filing fees or similar fee and applicable Taxes payable to a Governmental Entity in connection with a Regulatory Approval.

If a Termination Fee Event occurs, the Company shall pay or cause to be paid to CDP Groupe Infrastructures Inc. (or to any of its affiliates as directed by notice in writing by CDPQ) the Termination Fee in accordance with Section 8.2(4) as liquidated damages.

For the purposes of this Agreement, “Termination Fee” means $28,400,000, and “Termination Fee Event” means the termination of this Agreement:

by the Purchaser, pursuant to Section 7.2(1)(iv)(b) [Change in Recommendation];

by the Company, pursuant to Section 7.2(1)(iii)(b) [Superior Proposal];

by the Company or the Purchaser, pursuant to Section 7.2(1)(ii)(a) [Arrangement Resolution not Approved] or Section 7.2(1)(ii)(b) [Effective Time not Prior to Outside Date], but only if:

prior to such termination in the case of a termination pursuant to Section 7.2(1)(ii)(b) [Effective Time not Prior to Outside Date], an Acquisition Proposal is publicly announced or otherwise publicly disclosed by any Person;

prior to the time of the Company Meeting in the case of a termination pursuant to Section 7.2(1)(ii)(a) [Arrangement Resolution not Approved], an Acquisition Proposal publicly announced or otherwise publicly disclosed by any Person and such Acquisition Proposal has not expired or been withdrawn prior to the time of the Company Meeting; and

within twelve months following the date of such termination, any Acquisition Proposal is consummated or any definitive agreement is entered into that contemplates any Acquisition Proposal and such Acquisition Proposal is later consummated (whether or not within twelve months following such termination).

If a Termination Fee Event occurs due to a termination of this Agreement by the Company pursuant to Section 7.2(1)(iii)(b) [Superior Proposal], the Termination Fee shall be paid prior to or concurrently with the occurrence of such Termination Fee Event. If a Termination Fee Event occurs due to a termination of this Agreement by the Purchaser pursuant to Section 7.2(1)(iv)(b) [Change in Recommendation], the Termination Fee shall be paid within two Business Days following such Termination Fee Event. If a Termination Fee Event occurs in the circumstances set out in Section 8.2(3)(iii) [Acquisition Proposal following Termination], the Termination Fee shall be paid within two Business Days following the consummation/closing of the Acquisition Proposal referred to therein. Any Termination Fee shall be paid, or caused to be paid, by the Company to CDP Groupe Infrastructures Inc. (or to any of its affiliates as directed by notice in writing by CDPQ) by wire transfer in immediately available funds to an account designated by the Purchaser. For greater certainty, in no event shall the Company be obligated to pay the Termination Fee on more than one occasion, whether the Termination Fee may be payable pursuant to one or more than one provision of this Agreement at the same or at different times and upon the occurrence of different events.

Any Termination Fee payable by the Company pursuant to this Agreement shall be paid free and clear of and without deduction or withholding for, or on account of, any present or future Taxes, unless such deduction or withholding is, or the Company reasonably believes such deduction or withholding is, required by Law. If the Company is, or reasonably believes it is, required by applicable Laws to deduct or withhold any Taxes from the payment of the Termination Fee, (i) the Company shall make such required deductions or withholdings, (ii) the Company shall remit the full amount deducted or withheld to the appropriate Governmental Entity in accordance with applicable Laws, and (iii) the amount so withheld and remitted shall be treated for purposes of this Section 8.2 as having been paid to CDP Groupe Infrastructures Inc. (or its applicable affiliates identified pursuant to Section 8.2(4)).

If a Reverse Termination Fee Event occurs, the Purchaser shall pay or cause to be paid to the Company the Reverse Termination Fee in accordance with Section 8.2(8) as liquidated damages.

For the purposes of this Agreement, “Reverse Termination Fee” means $35,000,000, and “Reverse Termination Fee Event” means the termination of this Agreement by the Company pursuant to Section 7.2(1)(iii)(a) [Purchaser Breach] or pursuant to Section 7.2(1)(iii)(c) [Failure to Fund].

If a Reverse Termination Fee Event occurs, the Reverse Termination Fee shall be paid as promptly as practicable (and in any event within two Business Days following such Reverse Termination Fee Event). Any Reverse Termination Fee shall be paid, or caused to be paid, by the Purchaser to the Company by wire transfer in immediately available funds to an account designated by the Company. For greater certainty, in no event shall the Purchaser be obligated to pay the Reverse Termination Fee on more than one occasion, whether the Reverse Termination Fee may be payable pursuant to one or more than one provision of this Agreement at the same or at different times and upon the occurrence of different events.

Any Reverse Termination Fee payable by the Purchaser pursuant to this Agreement shall be paid free and clear of and without deduction or withholding for, or on account of, any present or future Taxes, unless such deduction or withholding is, or the Purchaser reasonably believes such deduction or withholding is, required by Law. If the Purchaser is, or reasonably believes it is, required by applicable Laws to deduct or withhold any Taxes from the payment of the Reverse Termination Fee, (i) the Purchaser shall make such required deductions or withholdings, (ii) the Purchaser shall remit the full amount deducted or withheld to the appropriate Governmental Entity in accordance with applicable Laws, and (iii) the amount so withheld and remitted shall be treated for purposes of this Section 8.2 as having been paid to the Company.

Each Party acknowledges that the agreements contained in this Section 8.2 are an integral part of the transactions contemplated by this Agreement, and that without these agreements the Parties would not enter into this Agreement. Each Party irrevocably waives any right it may have to raise as a defence that any such amounts are excessive or punitive. If the Company or the Purchaser, as the case may be, fails to timely pay any

amount due pursuant to this Section 8.2, it shall also pay any costs and expenses incurred by the other Party in connection with a legal action to enforce this Agreement that results in a judgment against the Company for the payment of the Termination Fee, together with interest on the amount of any unpaid fee, cost or expense at the prime rate of the Bank of Canada from the date such fee, cost or expense was required to be paid to (but excluding) the payment date. In no event shall, (i) the Company be obligated to pay the Termination Fee on more than one occasion or (ii) the Purchaser be obligated to pay the Reverse Termination Fee (including as a consequence of payment thereof by the Equity Investors pursuant to the Guarantee) on more than one occasion, in each case, whether or not the Termination Fee or the Reverse Termination Fee, as applicable, may be payable at different times or upon the occurrence of different events.

Subject to the Company’s right to injunctive and other equitable relief or other form of specific performance in accordance with Section 8.6 to prevent breaches or threatened breaches of this Agreement and to enforce compliance with the terms of this Agreement and the indemnification or reimbursement obligations of the Purchaser under Section 2.4(5), Section 4.8(3) or Section 4.11(1), in the event that the Reverse Termination Fee is paid to the Company in circumstances for which such fee is payable, payment of the Reverse Termination Fee (including as a consequence of payment thereof by the Equity Investors pursuant to the Guarantee) shall be the sole and exclusive remedy of the Company and its Subsidiaries against the Purchaser or any of its former, current or future general or limited partners, stockholders, financing sources (including, without limitation, the Debt Financing Sources and the Equity Investors), managers, members, directors, officers or affiliates (collectively, the “Purchaser Related Parties”) for any loss suffered as a result of the failure of the Arrangement or the transactions contemplated hereby to be consummated or for a breach or failure to perform any obligations required to be performed under this Agreement or otherwise relating to or arising out of this Agreement or the Arrangement, and upon payment of such amount none of the Purchaser Related Parties shall have any further liability or obligation relating to or arising out of this Agreement or the Arrangement, and no Company Related Party shall seek to obtain any recovery, judgment, or damages of any kind, including consequential, indirect, or punitive damages, against any Purchaser Related Party in connection with this Agreement or the transactions contemplated by this Agreement (except that the Guarantors shall be obligated pursuant to the terms and conditions of the Guarantee).

Subject to the Purchaser’s right to injunctive and other non-monetary equitable relief or specific performance in accordance with Section 8.6 to prevent breaches or threatened breaches of this Agreement and to enforce compliance with the terms of this Agreement, and the reimbursement obligations of the Company under Section 8.2(10), in the event that the Termination Fee is paid to the Purchaser in circumstances for which such fee is payable, payment of the Termination Fee shall be the sole and exclusive remedy of any Purchaser Related Parties against the Company or any of its former, current or future general or limited partners, stockholders, financing sources, managers, members, directors, officers or affiliates (collectively, the “Company Related Parties”) for any loss suffered as a result of the failure of the Arrangement or the transactions contemplated hereby to be consummated or for a breach or failure to perform all obligations required to be performed under this Agreement or otherwise relating to or

arising out of this Agreement or the Arrangement, and upon payment of such amount none of the Company Related Parties shall have any further liability or obligation relating to or arising out of this Agreement or the Arrangement, and no Purchaser Related Party shall seek to obtain any recovery, judgment, or damages of any kind, including consequential, indirect, or punitive damages, against any Company Related Party in connection with this Agreement or the transactions contemplated by this Agreement.

If this Agreement has been terminated by the Purchaser pursuant to Section 7.2(1)(iv)(a) [Company Breach], then the Company shall, within two (2) business days after receipt from Purchaser of documentation supporting its reasonably incurred expenses in connection with this Agreement, pay to CDP Groupe Infrastructures Inc. (or to any of its affiliates as directed by notice in writing by CDPQ) up to $3,000,000 on account of its reasonably incurred and documented expenses in connection with this Agreement. For greater certainty, no amount shall be payable under this Section 8.2(13) in the event that the Termination Fee is paid and in no event shall the sum of the reimbursed expenses under this Section 8.2(13) and the Termination Fee payable by the Company exceed an amount equal to the Termination Fee.

to the Purchaser at:

▇▇▇▇▇▇▇▇, ▇▇▇▇▇▇, ▇▇▇▇▇▇

▇▇▇ ▇▇▇

Attention:

Email:

                              /                              

with a copy (which shall not constitute notice) to:

Torys LLP

▇▇ ▇▇▇▇▇▇▇▇▇▇ ▇▇. ▇., ▇▇▇▇▇ ▇▇▇▇

▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇, ▇▇▇▇▇▇

▇▇▇ ▇▇▇

Attention:

▇▇▇▇▇ ▇▇▇▇▇▇▇ / ▇▇▇▇▇▇▇ ▇▇▇▇▇▇

Facsimile:

(▇▇▇) ▇▇▇-▇▇▇▇

Email:

▇▇▇▇▇▇▇▇@▇▇▇▇▇.▇▇▇ / ▇▇▇▇▇▇▇@▇▇▇▇▇.▇▇▇

to the Company at:

Student Transportation Inc.

▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇ ▇▇▇▇▇

▇▇▇▇▇ ▇▇▇

▇▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇

Attention:

▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇▇

Email:

with a copy (which shall not constitute notice) to:

Goodmans LLP

▇▇▇ ▇▇▇ ▇▇., ▇▇▇▇▇ ▇▇▇▇

▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇, ▇▇▇▇▇▇

▇▇▇ ▇▇▇

Attention:

▇▇▇▇▇▇ ▇▇▇▇ / ▇▇▇▇▇ ▇▇▇ ▇▇▇▇▇▇

Email:

▇▇▇▇▇@▇▇▇▇▇▇▇▇.▇▇ / ▇▇▇▇▇▇▇▇▇▇@▇▇▇▇▇▇▇▇.▇▇

The Parties agree that irreparable harm would occur for which money damages would not be an adequate remedy at law in the event that any of the provisions of this Agreement were not performed in accordance with their specific terms or were otherwise breached. It is accordingly agreed that the Parties shall be entitled to injunctive and other equitable relief to prevent breaches of this Agreement, and to enforce compliance with the terms of

this Agreement (including the Parties’ obligations to consummate the Arrangement and the Purchaser’s obligation to pay, and the right of the Company Securityholders to receive, the aggregate amount payable by the Company and the Purchaser contemplated by the Plan of Arrangement) without any requirement for the securing or posting of any bond in connection with the obtaining of any such injunctive or other equitable relief, this being in addition to any other remedy to which the Parties may be entitled at law or in equity. The Parties shall not object to the granting of injunctive or other equitable relief on the basis that there exists an adequate remedy at law. If, prior to the Outside Date, any Party brings any action in accordance with this Section 8.6 to enforce specifically the performance of the terms and provisions hereby by any other Party, the Outside Date shall automatically be extended (i) for the period during which such action is pending, plus 20 Business Days or (ii) by such other time period established by the court presiding over such action, as the case may be.

For greater certainty, it is acknowledged and agreed that the Company shall be entitled to seek specific performance as a third party beneficiary of the Purchaser’s rights against the Equity Investors under the Equity Commitment Letter and/or to seek specific performance to cause the Purchaser to enforce the obligations of the Equity Investors, under the Equity Commitment Letter, as set out in Section 8.6(1); provided, however, that such right shall only be available if, and only if: (i) all conditions in Section 6.1 and Section 6.2 have been satisfied or waived by the applicable Party or Parties (excluding conditions that, by their terms, are to be satisfied on the Effective Date, but are reasonably capable of being satisfied by the Effective Date); (ii) the Purchaser fails to consummate the Arrangement on the date on which the Effective Date should have occurred pursuant to Section 2.9(2); (iii) the Debt Financing provided for by the Debt Commitment Letter (or any alternative financing to the Debt Financing contemplated by Section 4.8) has been funded or will be funded in accordance with the terms thereof on the Effective Date if the Equity Financing is funded on the Effective Date; and (iv) the Company has irrevocably confirmed that if specific performance is granted and the Equity Financing and Debt Financing (or any alternative financings thereto contemplated by Section 4.8) are funded, it is ready, willing and able to consummate the Arrangement. For the avoidance of doubt, and notwithstanding anything in this Agreement to the contrary, the Company may concurrently pursue both (i) a grant of specific performance as a third party beneficiary of the Purchaser’s rights against the Equity Investors under the Equity Commitment Letter, to seek specific performance to cause the Purchaser to enforce the obligations of the Equity Investors, under the Equity Commitment Letter and/or to consummate the Arrangement, in each case, to the extent permitted by this Section 8.6(2) and (ii) the payment of the Reverse Termination Fee pursuant to Section 8.2(6) (and the payment of any amounts pursuant to Section 2.4(5), Section 4.8(3) or Section 4.11(1)); provided that under no circumstances shall the Company be entitled to receive both (a) a grant of specific performance as a third party beneficiary of the Purchaser’s rights against the Equity Investors under the Equity Commitment Letter, to seek specific performance to cause the Purchaser to enforce the obligations of the Equity Investors, under the Equity Commitment Letter and/or to consummate the Arrangement, in each case, to the extent permitted by this Section 8.6(2) and (b) payment of the Reverse Termination Fee pursuant to Section 8.2(6)(and the payment of any amounts pursuant to Section 2.4(5), Section 4.8(3) or Section 4.11(1)).

Except as provided in Section 2.4(5), Section 4.8(3), Section 4.10, Section 4.11(1) and Section 8.14, which, without limiting their terms, are intended as stipulations for the irrevocable benefit of the Indemnified Persons and of the other Persons identified therein as the beneficiaries thereof, and except for the right of the Common Shareholders to receive the Consideration and the right of the holders of Incentive Securities and Company Debentures to receive the amount payable in respect thereof in connection with the Arrangement, in each case, following the Effective Time and in accordance with the terms of this Agreement, the Company and the Purchaser intend that this Agreement will not benefit or create any right or cause of action in favour of any Person other than the Parties and that no Person, other than the Parties, shall be entitled to rely on the provisions of this Agreement in any Proceeding or other forum.

Despite the foregoing, the Parties acknowledge to each of the Indemnified Persons and each of the other Persons identified as being entitled to indemnification in Section 2.4(5), Section 4.8(3), Section 4.10 and Section 4.11(1), their direct rights against the applicable Party under Section 2.4(5), Section 4.8(3), Section 4.10 and Section 4.11(1), which are intended for the benefit of, and shall be enforceable by, each Indemnified Person and each such other Person, his or her heirs and his, her or its legal representatives, and for such purpose, the Company and the Purchaser, as applicable, confirms that it is acting as trustee on their behalf, and agrees to enforce such provisions on their behalf and that such provisions shall be binding on the Purchaser and its successors. The Parties reserve the right to vary or rescind their rights at any time and in any way whatsoever, if any, granted by or under this Agreement to any Person, including any Indemnified Person.

Despite the foregoing, the Parties acknowledge to each of the Debt Financing Sources their direct rights under Section 8.1, Section 8.2(11), Section 8.7, Section 8.12(3), (4) and (5) and Section 8.17, which are intended for the benefit of, and shall be enforceable by, each Debt Financing Sources, his or her heirs and his or her legal representatives, and for such purpose, the Company and the Purchaser, as applicable, confirms that it is acting as trustee on their behalf, and agrees to enforce such provisions on their behalf and that such provisions shall be binding on the Purchaser and its successors.

This Agreement becomes effective only when executed by the Company and the Purchaser. After that time, it will be binding upon and enure to the benefit of the Company and the Purchaser and their respective successors and permitted assigns.

Neither this Agreement nor any of the rights or obligations under this Agreement are assignable or transferable by any Party without the prior written consent of the other Party, provided that the Purchaser may assign all or part of its rights under this Agreement to, and all or part of its obligations under this Agreement may be assumed by, any of its affiliates if the Purchaser continues to be liable jointly and severally with such affiliate for all of its obligations hereunder.

This Agreement will be governed by and interpreted and enforced in accordance with the laws of the Province of Ontario and the federal laws of Canada applicable therein.

Each Party irrevocably attorns and submits to the exclusive jurisdiction of the courts of Ontario in the City of Toronto and waives objection to the venue of any Proceeding in such court or that such court provides an inconvenient forum, provided that any court Proceedings will be conducted in the English language.

Notwithstanding anything herein to the contrary, unless otherwise provided in the Debt Commitment Letter, each of the Company and the Purchaser agrees that any claim, controversy or dispute of any kind or nature (whether based upon contract, tort or otherwise) against a Lender that is in any way related to this Agreement or any of the transactions contemplated hereby, including any dispute arising out of or relating in any

way to the Debt Financing shall be governed by, and construed in accordance with, the laws of the State of New York without regard to conflict of law principles.

Notwithstanding anything herein to the contrary, unless otherwise provided in the Debt Commitment Letter, each of the Company and the Purchaser agrees (i) that it will not bring or support any action, cause of action, claim, cross-claim or third-party claim of any kind or description, whether in law or in equity, whether in contract or in tort or otherwise, against the Debt Financing Sources in any way relating to this Agreement or any of the transactions contemplated hereby, including any dispute arising out of or relating in any way to the Debt Financing or the performance thereof or the transactions contemplated thereby, in any forum other than exclusively in the Supreme Court of the State of New York, County of New York, or, if under applicable law exclusive jurisdiction is vested in the federal courts, the United States District Court for the Southern District of New York (and appellate courts thereof), (ii) submits for itself and its property with respect to any such action to the exclusive jurisdiction of such courts, (iii) agrees that service of process, summons, notice or document by registered mail addressed to it at its address provided in Section 8.3 shall be effective service of process against it for any such action brought in any such court, (iv) waives and hereby irrevocably waives, to the fullest extent permitted by law, any objection which it may now or hereafter have to the laying of venue of, and the defense of an inconvenient forum to the maintenance of, any such action in any such court, and (v) agrees that a final judgment in any such action shall be conclusive and may be enforced in other jurisdictions by suit on the judgment or in any other manner provided by law.

NOTWITHSTANDING ANYTHING HEREIN TO THE CONTRARY, THE COMPANY AND EACH OTHER PARTY HERETO HEREBY IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY LAW, ALL RIGHTS OF TRIAL BY JURY IN ANY ACTION, PROCEEDING, OR COUNTERCLAIM (WHETHER BASED UPON CONTRACT, TORT OR OTHERWISE) ARISING OUT OF OR RELATING TO THIS AGREEMENT, THE ACQUISITION, THE DEBT FINANCING OR ANY OF THE OTHER TRANSACTIONS CONTEMPLATED HEREBY OR THEREBY, INCLUDING IN ANY ACTION, PROCEEDING OR COUNTERCLAIM AGAINST ANY FINANCING SOURCE.

Headings, etc. The division of this Plan of Arrangement into Articles and Sections and the insertion of headings are for convenient reference only and do not affect the construction or interpretation of this Plan of Arrangement.

Currency. All references to “dollars” or to “$” are references to U.S. dollars, unless specified otherwise.

Gender and Number. Any reference to gender includes all genders. Words importing the singular number only include the plural and vice versa.

Certain Phrases, etc. The words (a) “including”, “includes” and “include” mean “including (or includes or include) without limitation”, (b) “or” is not exclusive, (c) “day” means “calendar day”, (d) “hereof”, “herein”, “hereunder” and words of similar import, shall refer to this Plan of Arrangement as a whole and not to any particular provision of this Plan of Arrangement, (e) “the aggregate of”, “the total of”, “the sum of”, or a phrase of similar meaning means “the aggregate (or total or sum), without duplication, of”, (f) “extent” in the phrase “to the extent” shall mean the degree to which a subject or other thing extends and such phrase shall not mean simply “if”, and (g) unless stated otherwise, “Article” or “Section” followed by a number or letter mean and refer to the specified Article or Section of this Plan of Arrangement.

Statutes and Rules. Any reference to a statute or to a rule of a self-regulatory organization, including any stock exchange, refers to such statute or rule and all rules, resolutions and regulations, administrative policy statements, instruments, blanket orders, notices, directions and rulings issued or adopted under it, as it or they may have been or may from time to time be amended or re-enacted, unless stated otherwise.

Date for Any Action. If the date on which any action is required to be taken hereunder is not a Business Day, such action shall be required to be taken on the next succeeding day

which is a Business Day. Any reference to a number of days shall refer to calendar days unless Business Days are specified.

Time. Time shall be of the essence in every matter or action contemplated hereunder. All times expressed herein are local time in Toronto, Ontario unless otherwise stipulated herein.

simultaneously:

each DSU outstanding immediately prior to the Effective Time shall be transferred by such holder to the Company in exchange for, subject to Section 4.4, a cash payment equal to the Consideration, and each such DSU shall immediately be cancelled;

any vesting conditions applicable to each PSG Unit outstanding immediately prior to the Effective Time shall accelerate in full (with PSG Units vesting based on a performance percentage of 100%) and each vested PSG Unit shall be transferred by such holder to the Company in exchange for, subject to Section 4.4, a cash payment equal to the Consideration, and each such PSG Unit shall immediately be cancelled;

the Indentures shall be amended (without any act, action or formality on the part of any Person, including the Company or the trustee under the indenture) to allow the immediate redemption of all Company Debentures outstanding immediately prior to the Effective Time for the Debenture Consideration;

the Company Debentures outstanding immediately prior to the Effective Time shall be redeemed by the Company in exchange for, subject to Section 4.4, a cash payment equal to the Debenture Consideration in respect of each C$1,000 of principal amount of such Company Debentures; with respect to each such Company Debenture:

the Company Debentureholders whose Company Debentures have been so redeemed shall cease to be holders of such Company Debentures and to have any rights as holders of such Company Debentures other than the right to receive the consideration to which such holders are entitled pursuant to this Section 2.3(b);

such Company Debentureholders’ names shall be removed from the register of the Company Debentures maintained by or on behalf of the Company; and

such Company Debentures shall be cancelled; and

simultaneously:

each Common Share held by a Dissenting Holder described in Section 3.1(a) shall be transferred by the holder thereof to the Purchaser in exchange for a debt claim against the Purchaser for the amount determined in accordance with Section 3.1(a) and thereupon such holder’s name shall be removed from the securities register of the Company in respect of such Common Share, the Purchaser, as the holder of such Common Share, shall be entered in the securities register of the Company as the holder thereof and each such Dissenting Holder shall cease to have rights as a holder other than the rights set out in Section 3.1; and

each Common Share held by a Common Shareholder (other than a Dissenting Holder described in Section 3.1(a)) shall be transferred by the holder thereof to the Purchaser in exchange for, subject to Section 4.4, a cash payment equal to the Consideration and thereupon such holder’s name shall be removed from the securities register of the Company in respect of such Common Share, the Purchaser, as the holder of such Common Share, shall be entered in the securities register of the Company as the holder thereof and each such Common Shareholder shall cease to

have rights as a holder other than the right to receive the consideration to which such holder is entitled pursuant to this Section 2.3(d)(ii);

ultimately are entitled to be paid fair value for such Common Shares shall: (i) in respect of such Common Shares be treated as not having participated in the transactions in Article 2 (other than Section 2.3(d)(i)); (ii) be entitled to be paid, subject to Section 4.4, the fair value of such Common Shares by the Purchaser, which fair value shall be determined as of the close of business on the day before the Arrangement Resolution was adopted at the Company Meeting; and (iii) not be entitled to any other payment or consideration, including any payment that would be payable under the Arrangement had such holders not exercised their Dissent Rights in respect of such Common Shares; or

ultimately are not entitled, for any reason, to be paid fair value for such Common Shares, shall in respect of such Common Shares be treated as having participated in the Arrangement on the same basis as a non-dissenting holder of Common Shares (and shall be entitled to receive the Consideration from the Purchaser in the same manner as such non-Dissenting Holders).

In no circumstances shall the Purchaser, the Company, the Depositary or any other Person be required to recognize a Person exercising Dissent Rights: (a) unless, as of the deadline for exercising Dissent Rights (as set forth in Section 3.1), such Person is the registered holder of those Common Shares in respect of which such Dissent Rights are sought to be exercised, (b) if such Person has voted or instructed a proxy holder to vote such Common Shares in favour of the Arrangement Resolution, or (c) unless such Person has strictly complied with the procedures for exercising Dissent Rights and does not withdraw such dissent prior to the Effective Time.

For greater certainty, in no case shall the Purchaser, the Company or any other Person be required to recognize Dissenting Holders as holders of the Common Shares in respect of which Dissent Rights have been validly exercised after the completion of the transfers under Section 2.3(d).

In addition to any other restrictions under Section 185 of the OBCA, none of the following shall be entitled to exercise Dissent Rights: (a) holders of Incentive Securities; (b) Company Debentureholders (in their capacity as a Company Debentureholder); (c) Common Shareholders who vote or have instructed a proxyholder to vote Common Shares in favour of the Arrangement Resolution; and (d) the Purchaser or its affiliates.

Following receipt of the Final Order and prior to the Effective Date:

the Purchaser shall deposit, or shall cause to be deposited, for the benefit of the Common Shareholders, cash with the Depositary in the aggregate amount equal to the payments in respect of the Common Shares required by this Plan of Arrangement, with the amount per Common Share in respect of which Dissent Rights have been exercised being deemed to be the Consideration for this purpose; and

the Company shall deposit, or shall cause to be deposited, for the benefit of the Company Debentureholders, cash with the Depositary in the aggregate amount equal to the payments in respect of the Company Debentures required by this Plan of Arrangement.

The consideration contemplated by Section 4.1(1) shall be held by the Depositary as agent and nominee for such Common Shareholders and Company Debentureholders in accordance with the provisions of Article 4 hereof. Upon surrender to the Depositary for cancellation of a certificate which immediately prior to the Effective Time represented outstanding Common Shares that were transferred pursuant to Section 2.3(d), together with a duly completed and executed Letter of Transmittal and such additional documents and instruments as the Depositary may reasonably require, the holder of such surrendered

certificate shall be entitled to receive, and the Depositary shall deliver (and the Purchaser shall cause the Depositary to deliver), to such holder a cheque (or other form of immediately available funds) representing the cash which such holder has the right to receive pursuant to the Plan of Arrangement in respect of such Common Shares, without interest and less any amounts withheld pursuant to Section 4.4, and any certificate so surrendered shall forthwith be cancelled.

The Depositary shall deliver the consideration in respect of those Company Debentures which are represented by a Global Debenture (as such term is defined in the applicable Indenture) to the Depository, as defined in the applicable Indenture, in accordance with normal industry practice for payments relating to securities held on a book-entry only basis. Company Debentureholders whose interest in the applicable Company Debentures is not represented by a Global Debenture shall, upon surrender to the Depositary for cancellation of a certificate or certificates which, immediately prior to the Effective Time, represented outstanding Company Debentures that were redeemed pursuant to Section 2.3(b) hereof, together with a duly completed and executed Letter of Transmittal and such additional documents and instruments as the Depositary may reasonably require, the holders of such Company Debentures represented by such surrendered certificate(s) shall be entitled to receive, and the Depositary shall deliver (and the Purchaser shall cause the Depositary to deliver) to such holder, a cheque (or other form of immediately available funds) representing the consideration which such Company Debentureholder has the right to receive under this Plan of Arrangement for each C$1,000 of principal amount of such Company Debentures, less any amounts withheld pursuant to Section 4.4 hereof, and any Company Debenture certificate(s) so surrendered shall forthwith be cancelled.

After the Effective Time and until surrendered for cancellation as contemplated by this Section 4.1, each certificate, agreement or other instrument (as applicable) which immediately prior to the Effective Time represented Common Shares or Company Debentures shall be deemed at all times to represent only the right to receive upon such surrender a cash payment in lieu of such certificate as contemplated in this Section 4.1.

Any certificate, agreement or other instrument that immediately prior to the Effective Time represented outstanding Common Shares or Company Debentures not duly surrendered with all other documents required by this Section 4.1(1) on or before the sixth anniversary of the Effective Date shall cease to represent a claim by or interest of any former holder thereof of any kind or nature against or in the Company or the Purchaser. On such date, all consideration to which such former holder was entitled under the Plan of Arrangement shall be deemed to have been surrendered to the Purchaser or Company, as applicable, together with all entitlements to dividends, distributions and interest thereon held for such former holder.

On the Effective Date, the Company shall deliver, or shall cause to be delivered, to each holder of Incentive Securities, as reflected on the register maintained by or on behalf of the Company in respect of such Incentive Securities, a cheque representing the cash payment, if any, which such holder of Incentive Securities has the right to receive under

this Plan of Arrangement for such Incentive Security, less any amounts withheld pursuant to Section 4.4 hereof.

Any payment made by way of cheque by the Depositary or the Company, as applicable, pursuant to this Plan of Arrangement that has not been deposited or has been returned to the Depositary or the Company, as applicable, or that otherwise remains unclaimed, in each case, on or before the sixth anniversary of the Effective Time, and any right or claim to payment hereunder that remains outstanding on the sixth anniversary of the Effective Time shall cease to represent a right or claim of any kind or nature and the right of the holder to receive the applicable consideration for the Common Shares, Company Debentures and Incentive Securities pursuant to this Plan of Arrangement shall terminate and be deemed to be surrendered and forfeited to the Purchaser or the Company, as applicable, for no consideration.

The Parties may amend, modify and/or supplement this Plan of Arrangement at any time and from time to time prior to the Effective Time, provided that each such amendment, modification and/or supplement must be (a) set out in writing, (b) approved by the Parties, each acting reasonably, (c) filed with the Court and, if made following the Company Meeting, approved by the Court, and (d) communicated to the Company Securityholders if and as required by the Court.

Any amendment, modification or supplement to this Plan of Arrangement may be proposed by any of the Parties at any time prior to the Company Meeting (provided that the other Parties have consented thereto) with or without any other prior notice or communication, and if so proposed and accepted by the Persons voting at the Company Meeting (other than as may be required under the Interim Order), shall become part of this Plan of Arrangement for all purposes.

Any amendment, modification or supplement to this Plan of Arrangement that is approved or directed by the Court following the Company Meeting shall be effective only if (a) it is consented to in writing by each of the Parties (in each case, acting reasonably), and (b) if required by the Court, it is consented to by some or all of the Common Shareholders voting in the manner directed by the Court. Any amendment, modification or supplement to this Plan of Arrangement may be made following the Company Meeting without filing such amendment, modification or supplement with the Court or seeking Court approval, provided that (i) it concerns a matter which, in the reasonable opinion of

the Parties, is of an administrative nature required to better give effect to the implementation of this Plan of Arrangement and is not adverse to the interest of any Company Securityholder or (ii) is an amendment contemplated in Section 2.4 or Section 5.1(4).

Any amendment, modification or supplement to this Plan of Arrangement may be made following the Effective Date unilaterally by the Purchaser, without communication to the Company Securityholders, provided that it concerns a matter which, in the reasonable opinion of the Purchaser, is of an administrative nature required to better give effect to the implementation of this Plan of Arrangement and is not adverse to the economic interest of any former Company Securityholder.

This Plan of Arrangement may be withdrawn prior to the Effective Time in accordance with the terms of the Arrangement Agreement.

The arrangement (as may be amended, supplemented or varied, the “Arrangement”) under Section 182 of the Business Corporations Act (Ontario) (the “OBCA”) involving Student Transportation Inc. (the “Company”), pursuant to the arrangement agreement among the Company, and Spinner Can Acquireco Inc. dated February 27, 2018, as it may be modified, supplemented or amended from time to time in accordance with its terms (the “Arrangement Agreement”), the full text of which is set out as Appendix [•] to the management information circular of the Company dated [•], 2018 (the “Circular”), and all transactions contemplated thereby, are hereby authorized, approved and adopted.

The plan of arrangement, the full text of which is set out as Appendix [•] to the Circular, as it has been or may be modified, supplemented or amended in accordance with the Arrangement Agreement and its terms, involving the Company (the “Plan of Arrangement”), is hereby authorized, approved and adopted.

The Arrangement Agreement and all the transactions contemplated therein, the actions of the directors of the Company in approving the Arrangement and the Arrangement Agreement and the actions of the directors and officers of the Company in executing and delivering the Arrangement Agreement and any modifications, supplements or amendments thereto are hereby ratified and approved.

Notwithstanding that this resolution has been passed (and the Arrangement adopted) by the Common Shareholders (as defined in the Arrangement Agreement) or that the Arrangement has been approved by the Ontario Superior Court of Justice (Commercial List) (the “Court”), the directors of the Company are hereby authorized and empowered, at their discretion, without further notice to or approval of the Common Shareholders: (a) to amend or modify the Arrangement Agreement or the Plan of Arrangement to the extent permitted by their terms; and (b) subject to the terms of the Arrangement Agreement, not to proceed with the Arrangement and any related transactions.

The Company is hereby authorized to apply for a final order from Court to approve the Arrangement in accordance with and subject to the terms and conditions set forth in the Arrangement Agreement and the Plan of Arrangement.

Any officer or director of the Company is hereby authorized and directed, for and on behalf of the Company, to execute or cause to be executed and to deliver or cause to be delivered, all such other documents and instruments and to perform or cause to be performed all such other acts and things as, in such person’s opinion, may be necessary or desirable to give full force and effect to the foregoing resolutions and the matters authorized thereby, such determination to be conclusively evidenced by the execution and delivery of such other document or instrument or the doing of any other such act or thing.

Organization and Qualification. The Company and each of its Subsidiaries is a corporation or other entity duly incorporated or organized, as applicable, validly existing and in good standing under the Laws of the jurisdiction of its incorporation or organization, and has all requisite power and authority and is qualified and holds all Authorizations required to carry on its business as now conducted and to own, lease or operate its assets and properties, except as to the extent that any failure of the Company or any of its Subsidiaries to be so qualified or to possess such Authorizations would not, individually or in the aggregate, have a Material Adverse Effect.

Authorization. The Company has the requisite corporate power and corporate authority to enter into and perform its obligations under this Agreement. The execution, delivery and performance by the Company of its obligations under this Agreement and the consummation of the Arrangement and the other transactions contemplated hereby have been duly authorized by all necessary action on the part of the Company, and no other proceedings on the part of the Company are necessary to authorize this Agreement or the consummation of the Arrangement and the other transactions contemplated hereby, other than approval of the Arrangement Resolution in the manner required by the Interim Order and Law and approval of the Arrangement by the Court.

Capitalization.

The authorized capital of the Company consists of an unlimited number of Common Shares of which 95,212,663 Common Shares were issued and outstanding as of close of business on the Business Day immediately preceding the date of this Agreement, and an unlimited number of preferred shares of which none were issued and outstanding as of the close of business on the Business Day immediately preceding the date of this Agreement. Each of the Common Shares referred to above have been duly authorized and validly issued as fully paid and non-assessable shares.

As of the close of business on the Business Day immediately preceding the date of this Agreement, the Company had C$75,000,000 aggregate principal amount of Company 2013 Debentures issued and outstanding and C$85,000,000 aggregate principal amount of Company 2016 Debentures issued and outstanding.

As of the date of this Agreement, there are: 964,184 PSG Units and 269,172 DSUs issued and outstanding. The Company Disclosure Letter sets forth the number of PSG Units and DSUs held by each holder thereof.

No Common Shares are issuable on the settlement of DSUs.

The Company has included in the Data Room true and complete copies of the PSG Plan and the DSU Plan.

Except as disclosed in clauses (a) through (e) above and other than as contemplated by the Company’s dividend reinvestment plan, there are no issued, outstanding or authorized options, equity-based awards, warrants, calls, conversion, pre-emptive, redemption, repurchase, stock appreciation or other rights, or any other agreements, arrangements, instruments or commitments of any kind that obligate the Company or any of its Subsidiaries to, directly or indirectly, issue or sell any securities of the Company or any of its Subsidiaries, or give any Person a right to subscribe for or acquire, any securities of the Company or any of its Subsidiaries.

Execution and Binding Obligation. This Agreement has been duly authorized and executed and delivered by the Company, and constitutes a legal, valid and binding obligation of the Company enforceable against the Company in accordance with its terms, except as enforcement thereof may be limited by bankruptcy, insolvency, reorganization, moratorium or other Laws related to or affecting the rights of creditors generally and, except as limited by the application of equitable principals (regardless of whether such enforcement is considered in a proceeding in equity or at Law), and by the fact that the right to indemnity, contribution and wavier, and the ability to sever unenforceable terms, may be limited by applicable Law.

Governmental Authorization. The execution, delivery and performance by the Company of its obligations under this Agreement and the consummation of the Arrangement and the other transactions contemplated hereby do not require any Authorization or other action by or in respect of, or filing with, or notification to, any Governmental Entity by the Company or by any of its Subsidiaries other than: (a) the Interim Order and any filings required in order to obtain, approvals required by, the Interim Order; (b) the Final Order, and any filings required to obtain the Final Order; (c) filings with the Director of the OBCA; (d) Required Regulatory Approvals; (e) filings with the Securities Authorities, the SEC, the TSX or NASDAQ; (vi) the Transportation Regulatory Approvals; and (f) any Authorizations which, if not obtained, or any actions by or in respect of, or filings with, or notifications to, any Governmental Entity which (i) if not taken or made, would not, individually or in the aggregate, have a Material Adverse Affect, or (ii) would be required solely as a result of the identity or the legal or regulatory status of the Purchaser or any of the Equity Investors.

Non-Contravention. The execution, delivery and performance by the Company of its obligations under this Agreement and the consummation of the Arrangement and the other transactions contemplated hereby do not and will not (or would not with the giving of notice, the lapse of time or the happening of any other event or condition):

contravene, conflict with, or result in any violation or breach of the Company Constating Documents or the organizational documents of any of its Subsidiaries;

assuming compliance with the matters referred to in Paragraph (5) above, contravene, conflict with or result in a violation or breach of any Law applicable to the Company or any of its Subsidiaries or any of their respective properties or

assets, except as would not, individually or in the aggregate, have or reasonably be expected to have a Material Adverse Effect;

allow any Person to exercise any rights, require any consent or notice to or other action by any Person, or constitute a default under, or cause or permit the termination, cancellation, acceleration or other change of any right or obligation or the loss of any benefit to which the Company or any of its Subsidiaries is entitled (including by triggering any rights of first refusal or first offer, change in control provision or other restriction or limitation) under any Contract or any Authorization to which the Company or any of its Subsidiaries is a party or by which the Company or any of its Subsidiaries is bound, except as would not, individually or in the aggregate, have or reasonably be expected to have a Material Adverse Effect; or

result in the creation or imposition of any Lien (other than Permitted Liens) upon any of the material properties or material assets of the Company or its Subsidiaries (excluding, for greater certainty, any Lien created or imposed by the Debt Financing).

Shareholders’ and Similar Agreement. None of the Company or any of its Subsidiaries is a party to any shareholder, pooling, voting or other similar arrangement or agreement relating to the ownership or voting of any of the securities of the Company or any Subsidiary and has not adopted a shareholder rights plan or any other similar plan or agreement.

Subsidiaries; Non-Controlled Entities.

A true and complete list of all Subsidiaries of the Company is set out in the Company Disclosure Letter, and the following information with respect to each such Subsidiary is set forth therein: (i) its name, (ii) the percentage owned directly or indirectly by the Company and the percentage owned by the registered holders of capital stock or other equity interests if other than the Company and its Subsidiaries, and (iii) its jurisdiction of incorporation, organization or formation.

A true and complete list of all Non-Controlled Entities which the Company, directly or indirectly, owns any interest is set out in Schedule 8(b) of the Company Disclosure Letter, and the following information with respect to each Non-Controlled Entity is set forth therein: (i) its name, (ii) the number of securities owned directly or indirectly by the Company, and (iii) its jurisdiction of incorporation, organization or formation.

Other than the Subsidiaries and the Non-Controlled Entities, the Company has no direct or indirect subsidiaries nor does it own any direct or indirect equity interest in any Person.

There are no Contracts, commitments, understandings or restrictions which require the Company’s Subsidiaries to issue, sell or deliver any shares or other ownership interests, or any securities convertible into or exchangeable for, any shares or other ownership interests.

The Company directly or indirectly owns all of the issued and outstanding shares, interests or partnership interests (however divided), as the case may be, of each of its Subsidiaries free and clear of any Liens (other than Permitted Liens), and all of the issued and outstanding shares, interests or partnership interests (however divided), as applicable, of each Subsidiary of the Company has been duly authorized and validly issued as fully paid and non-assessable shares, interests or partnerships interests (however divided).

Securities Law Matters. The Company is a “reporting issuer” under Securities Laws in each of the provinces and territories of Canada and is registered as a U.S. reporting company under Section 12(b) of the US Exchange Act. The Common Shares, the Company 2013 Debentures and the Company 2016 Debentures are listed and posted for trading on the TSX and the Common Shares are also listed and posted for trading on NASDAQ. None of the Company’s Subsidiaries are subject to continuous or periodic or other disclosure requirements under the securities laws of any jurisdiction. The Company is not in default of any material requirements of any Securities Laws, the US Exchange Act, or the rules and regulations of the TSX or NASDAQ. The Company has not taken any action to cease to be a reporting issuer in any province or territory of Canada nor has the Company received notification from any Governmental Entity seeking to revoke the reporting issuer status of the Company. No delisting, suspension of trading or cease trade or other order or restriction with respect to any securities of the Company is pending, in effect or, to the knowledge of the Company, has been threatened, or is expected to be implemented or undertaken (other than in connection with the transactions contemplated by this Agreement), and, to the knowledge of the Company, the Company is not subject to any formal or informal review, enquiry, investigation or other proceeding relating to such order or restriction. The Company has, since June 30, 2017, filed or furnished with the applicable Securities Authorities, the SEC, the TSX and NASDAQ all documents and other materials required to be filed or furnished by the Company under Securities Laws with such Securities Authorities, the SEC, the TSX and/or NASDAQ, as applicable, in accordance with the applicable Laws of such Securities Authorities, the SEC, the TSX and/or NASDAQ. The documents comprising the Company Filings, as of the their respective dates (or, if amended or superseded by a subsequent filing, at the time filed), complied in all material respects with securities Law and did not contain any Misrepresentation. The Company has not filed any confidential material change report or any other confidential filings with any Securities Authority or the SEC, which at the date of this Agreement remains confidential. As of the date of this Agreement, there are no outstanding or unresolved comments in comment letters from any Securities Authority or the SEC with respect to any of the Company’s filings and, to the Company’s knowledge, neither the Company nor any of the Company filings is subject to an ongoing audit, review, comment or investigation by any Securities Authority or the SEC or any of the TSX or NASDAQ.

Financial Statements. The Company’s audited consolidated financial statements as at and for the fiscal years ended June 30, 2017 and 2016 (including the notes thereto) and the unaudited consolidated interim financial statements as at and for the three and six months ended December 31, 2017 (including any of the notes thereto) (collectively, the “Company Financial Statements”), and all financial statements of the Company which are publicly disseminated by the Company in respect of any subsequent periods prior to the Effective Date: (a) were, or will be, prepared in accordance with GAAP consistently applied throughout the periods referred to therein; (b) fairly present, or will fairly present, in all material respects, the consolidated financial position of the Company as at such dates and its financial performance and cash flows for the periods then ended (except (i) in the case of unaudited quarterly financial statements, to normal year-end adjustments and the omission of notes which are not required by applicable Laws in the unaudited statements and (ii) as otherwise indicated in such financial statements and the notes thereto or, in the case of audited statements, in the related report of the Company’s independent auditors, as the case may be), and there have been no changes in accounting methods, policies or practices of the Company of its Subsidiaries since December 31, 2017.

Disclosure Controls and Internal Control over Financial Reporting.

The Company has established and maintains a system of disclosure controls and procedures that are designed to provide reasonable assurance that information required to be disclosed by the Company in its annual filings, interim filings or other reports filed or submitted by it under Securities Laws is recorded, processed, summarized and reported within the time periods specified in Securities Laws. Such disclosure controls and procedures include controls and procedures designed to ensure that information required to be disclosed by the Company in its annual filings, interim filings or other reports filed or submitted under Securities Laws is accumulated and communicated to the Company’s management, including its chief executive officer and chief financial officer, as appropriate, to allow timely decisions regarding required disclosure.

The Company has established and maintains a system of internal control over financial reporting that is designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with GAAP.

As of the date hereof, neither the Company, nor to the knowledge of the Company, the Company’s auditors, has identified or been made aware of any material weakness (as such term is defined in National Instrument 52-109 – Certification of Disclosure in Issuers’ Annual and Interim Filings) relating to the design, implementation or maintenance of the Company’s internal control over financial reporting, or fraud, whether or not material, that involves management or other employees who have a significant role in the internal control over financial reporting of the Company. To the knowledge of the Company, none of the Company or any of its Subsidiaries, or any of their respective directors,

officers, auditors, accountants or representatives has received or otherwise obtained knowledge of any complaint, allegation, assertion, or claim, whether written or oral, regarding accounting, internal accounting controls or auditing matters, including any complaint, allegation, assertion, or claim that the Company or any of its Subsidiaries as engaged in questionable accounting or auditing practices, or any expression of concern from its employees regarding questionable accounting or auditing matters.

Books and Records. The financial books, records and accounts of the Company: (a) have been maintained in all material respects accordance with applicable Laws; (b) accurately and fairly reflect the material transactions, acquisitions and dispositions of the assets of Company; and (c) accurately and fairly reflect the basis for the Company’s financial statements.

Minute Books. The corporate minute books of the Company have been maintained in accordance with, in all material respects, applicable Laws and are complete and accurate in all material respects.

No Undisclosed Material Liabilities. There are no material liabilities or obligations of the Company or of any of its Subsidiaries of any nature, whether accrued, contingent, absolute, determined, determinable or otherwise, other than liabilities or obligations: (a) disclosed in the audited consolidated financial statements of the Company as at and for the fiscal years ended June 30, 2017 and 2016 (including any notes or schedules thereto) included in the Company Filings; (b) incurred in the Ordinary Course since June 30, 2017; (c) not required to be set forth in the Company Filings under GAAP; (d) incurred in connection with this Agreement or the transactions contemplated hereby; (e) that relate to Taxes or (f) that are not and would not, individually or in the aggregate with all other liabilities and obligations of the Company and its Subsidiaries (other than those disclosed in the Company Filings and/or in the notes to the Company financial statements), reasonably be expected to have a Material Adverse Effect. None of the Company or any of its Subsidiaries is a party to, or has any commitment to become a party to, any joint venture, off balance sheet partnership or any similar agreement (including any agreement or arrangement relating to any transaction or relationship between or among the Company or any of its Subsidiaries, on the one hand, and any unconsolidated entity, including any structured finance, special purpose, or limited purpose entity or person, on the other hand) or any “off balance sheet arrangements” (as defined in the instructions thereto of Form 51-102F1 of National Instrument 51-102 – Continuous Disclosure Obligations) where the result, purpose or effect of such agreement or arrangement is to avoid disclosure, of any transaction involving, or liabilities of, the Company or any of its subsidiaries in the Company’s or such Subsidiary’s financial statements or any other documents filed by the Company under applicable Securities Laws.

Absence of Certain Changes or Events. Since June 30, 2017 until the date of this Agreement, other than the transactions contemplated in this Agreement or as publicly disclosed in the Company Filings and except as otherwise permitted by Section 4.1, the

business of the Company and of each of its Subsidiaries has been conducted in the Ordinary Course and no change, event, occurrence, effect, state of facts or circumstances has occurred that would reasonably be expected to, individually or in the aggregate, have a Material Adverse Effect.

Related Party Transactions. Except as contemplated by this Agreement, no director or officer of the Company or any of its Subsidiaries or holder of record or beneficial owner of 5% or more of the Common Shares, or associate or affiliate of any such officer, director or beneficial owner, is a party to any material loan, guarantee, contract, arrangement or understanding (excluding any employment related contract, arrangement or understanding) or other transactions with the Company or any of its Subsidiaries, or any of their respective affiliates or associates.

Compliance with Law. The Company and each of its Subsidiaries are, and since June 30, 2016 have been, conducting its business in accordance with applicable Law in each jurisdiction in which it carries on business, except for any such non-compliances which would not reasonably be expected to have a Material Adverse Effect, and none of the Company or any of its Subsidiaries, or, to the knowledge of the Company, any of the directors or officers of the Company or the Company’s Subsidiaries, has received a notice of material non-compliance or investigation with respect to material non-compliance, and, to the knowledge of the Company, no investigation by any Governmental Entity with respect to the Company or any Company Subsidiary is pending.

Authorizations. The Company and each of its Subsidiaries own, possess or have obtained all material Authorizations that are required by Law in connection with the operation of the business of the Company and each of its Subsidiaries as presently conducted, or in connection with the ownership, operation or use of the Company Assets, except, in each case, as would not reasonably be expected to have a Material Adverse Effect. To the knowledge of the Company, no event has occurred which, with the giving of notice, lapse of time or both, would reasonably be likely constitute a default under, or in respect of, any such material Authorization, except, in each case, as would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect. Each such Authorization is valid and in full force and effect, and is renewable by its terms or in the Ordinary Course, except where such failure to be in full force and effect or to be renewable, would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect.

Material Contracts.

True and complete copies of the Material Contracts, together with all material amendments thereto, have been provided in the Data Room. The Company Disclosure Letter sets out a complete and accurate list of all Material Contracts.

As of the date of this Agreement, each Material Contract is legal, valid, binding and in full force and effect and is enforceable against the Company or a Subsidiary of the Company that are a party thereto, in accordance with its terms

(subject to bankruptcy, insolvency, reorganization, moratorium or other Laws related to or affecting the rights of creditors generally, and to general principles of equity).

None of the Company or any of its Subsidiaries is in breach or default under any Material Contract, nor does the Company have knowledge of any condition that with the passage of time or the giving of notice or both would result in such a breach or default, except in each case where any such breaches or defaults would not, individually or in the aggregate, reasonably be expected to result in, or result in, a Material Adverse Effect.

There is no, nor has the Company received any written notice of, any breach or default under nor, to the knowledge of the Company, does there exist any condition which with the passage of time or the giving of notice or both would result in such a breach or default under any such Material Contract by any other party to a Material Contract, except in each case where any such breaches or defaults would not, individually or in the aggregate, reasonably be expected to result in, or result in, a Material Adverse Effect.

None of the Company or any of its Subsidiaries has received any written notice that any party to a Material Contract intends to cancel, terminate or otherwise adversely modify or not renew its relationship with the Company or any of its Subsidiaries, and to the knowledge of the Company, no such action has been threatened, which, in either case, individually or in the aggregate, would reasonably be expected to result in, or result in, a Material Adverse Effect.

Restrictions on Conduct of Business. None of the Company or any of its Subsidiaries is a party to or bound by any non-competition agreement or any other agreement, obligation, judgment, injunction, order or decree which purports to: (a) limit the manner or the localities in which all or any portion of the business of the Company or its Subsidiaries are conducted; (b) limit any business practice of the Company or any of its Subsidiaries; or (c) restrict any acquisition or disposition of any property by the Company or by any of its Subsidiaries, except, in each case, any such limitation or restriction which would not, individually or in the aggregate, reasonably be expected to result in, or result in, a Material Adverse Effect.

Real Property.

Except as would not reasonably be expected to have a Material Adverse Effect (i) the Company or one its Subsidiaries have good and marketable title in fee simple to all freehold real or immovable property owned by them (the “Company Owned Properties”) free and clear of any Liens, (ii) none of the Company or any of its Subsidiaries is the owner of, or subject to any agreement or option to own any real or immovable property or any interest in real or immovable property, other than the Company Owned Properties, and (iii) none of the Company or any of its Subsidiaries has received written notice that any of the Company Owner

Properties is subject to any decree of or order by a Governmental Entity to be sold or is being condemned, expropriated or otherwise taken by any public authority, nor to the knowledge of the Company has any such condemnation, expropriation or taking been proposed.

Neither the Company nor any of its Subsidiaries is party to, or bound by, any agreement to sell, transfer or acquire any interest in any real property.

A complete list of all Company Owned Properties setting forth the municipal address of each of them, has been disclosed in the Company Disclosure Letter.

Except as would not reasonably be expected to have a Material Adverse Effect, each Company Lease (i) is in good standing, legal, valid, binding and in full force and effect and is enforceable by the Company and its Subsidiaries, as applicable, in accordance with its terms (subject to any limitation under bankruptcy, insolvency, reorganization, moratorium or other Laws related to or affecting the rights of creditors generally and the discretion that a court may exercise in the granting of equitable remedies such as specific performance and injunction), and (ii) there exists no event of default or event, occurrence, condition or act which, with the giving of notice, the lapse of time or the happening of any other event or condition, would become an event of default under the Company Leases and to the knowledge of the Company, none of the Company or any of its Subsidiaries has received or delivered any written notice of any breach of, or default under, any Company Lease. The Company has delivered or made available for inspection a true, complete and correct copy, in all material respects, of all Company Leases (together with all amendments, extensions or additions thereto).

Personal Property. Each of the Company and its Subsidiaries is the owner of all of its material personal property and assets with good and marketable title thereto free of any Liens, except (a) for Permitted Liens, (b) school buses and similar vehicles, and (c) as would not reasonably be expected to have a Material Adverse Effect. The Company and its Subsidiaries, as lessees, have the right under valid and subsisting leases to use, possess and control all personal property leased by and material to the Company or any of its Subsidiaries as used, possessed and controlled by the Company or its Subsidiaries, as applicable, except (i) for Permitted Liens, (ii) school buses and similar vehicles, and (iii) as would not reasonably be expected to have a Material Adverse Effect.

Intellectual Property.

Except as would not, individually or in the aggregate, would not reasonably be expect to have a Material Adverse Effect, (i) the Company and its Subsidiaries own all rights, title and interest in and to, or have validly licensed (and are not in breach of such licenses) to use or otherwise exploit, the Intellectual Property necessary to carry on the business now operated by them and (ii) there has been no infringement by the Company or any of its Subsidiaries or breach by the Company or any of its Subsidiaries of any Intellectual Property that necessary to

carry on the business now operated by them. All employees or contractors of the Company and its Subsidiaries who have authored, conceived, created or developed any Intellectual Property while employed or engaged by the Company or its Subsidiaries have assigned all of their rights in such intellectual property to one of the Company or its Subsidiaries, as applicable, and waived all non-assignable Intellectual Property rights therein, except for any failures to execute so assign or waive that, individually or in the aggregate, would not reasonably be expected to have a Material Adverse Effect. A true, complete and accurate list of the registrations or applications of Intellectual Property owned by the Company and its Subsidiaries is set out in the Company Disclosure Letter.

To the knowledge of the Company, none of the Intellectual Property owned by the Company or its Subsidiaries is subject to any judgment, order or decree restricting the use, distribution, transfer, or licensing thereof by the Company or any of its Subsidiaries.

As of the date of this Agreement, there are no Proceedings pending, or to the knowledge of the Company, threatened in writing, alleging any infringement, misappropriation, or other violation by the Company or any Subsidiary of the Intellectual Property of any Person in a manner that has or could reasonably be expected to result in a material liability to the Company and its Subsidiaries, taken as a whole, and there is no Proceeding pending or threatened in writing by any Person challenging the Company’s or its Subsidiaries’ rights in or to the Intellectual Property owned by the Company or its Subsidiaries.

As of the date of this Agreement, to the knowledge of the Company, all computer hardware and operating systems, software, database engines and processed data, technology infrastructure and other computer systems used in connection with the conduct of the business of the Company and its Subsidiaries (the “Business Systems”) as presently conducted are sufficient, in all material respects, for conducting the business of the Company and its Subsidiaries as presently conducted. Except as has not been or as would not reasonably be expected to be, individually or in the aggregate, result in a Material Adverse Effect to the Company and its Subsidiaries, taken as a whole, in the last twelve (12) months, there has not been any failure with respect to any of the Business Systems that has not been remedied or replaced.

Notwithstanding any other provisions of this Agreement to the contrary, the representations and warranties made in this Paragraph (23) of this Schedule D are the sole and exclusive representations and warranties made by the Company in this Agreement with respect to Intellectual Property matters.

Litigation. As of the date of this Agreement, there are no material Proceedings that have been commenced or, to the knowledge of the Company, threatened against the Company or any of its Subsidiaries, affecting any of their respective properties or assets by or before any Governmental Entity, which, if adversely determined, would have, or would

reasonably be expected to have, a Material Adverse Effect. As of the date of this Agreement, none of the Company or the Subsidiaries or any of their respective properties or assets is subject to any outstanding judgment, order, writ, injunction or decree of any Governmental Entity which has, had or is reasonably likely to have, a Material Adverse Effect or which would prevent or materially delay consummation of the transactions contemplated by this Agreement. As of the date of this Agreement, no bankruptcy, liquidation, winding-up or other similar proceeding that has been commenced, or, to the knowledge of the Company, threatened against or relating to the Company or any of its Subsidiaries before any Governmental Entity.

Environmental Matters.

The Company, each of its Subsidiaries, and each of their respective assets, properties and businesses have been since January 1, 2014 and are in compliance with all Environmental Laws, except for such instances where the failure to comply would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.

As of the date of this Agreement, none of the Company or its Subsidiaries (i) is subject to any Proceeding, or to the knowledge of the Company, investigation or order under or related to any Environmental Laws, or (ii) has received any written notice, or has become aware, of any material non-compliance in respect of, or any material liability under, any Environmental Laws that is still outstanding.

To the knowledge of the Company, none of the Company or its Subsidiaries has caused or permitted, or is otherwise responsible for, the release, spill, emission, discharge, presence or migration of any Hazardous Substances on or from any Company Owned Real Property or real property leased or subleased, by the Company or any of its Subsidiaries, except (i) in compliance with Environmental Laws, (ii) in compliance with any applicable contractual obligations of the Company and its Subsidiaries, including under the Company Leases and (iii) as would not result in a material liability to the Company and its Subsidiaries, taken as a whole.

The Data Room contains true and complete, in all material respects, copies and results of any material reports, studies, analyses, tests and monitoring information and any other material documents or correspondence possessed or initiated by the Company or its Subsidiaries relating to Environmental Laws or Hazardous Substances (including any potential liabilities related to the foregoing) that have been prepared in the last 3 years.

Notwithstanding any other provisions of this Agreement to the contrary, the representations and warranties made in this Paragraph (25) of this Schedule D are the sole and exclusive representations and warranties made by the Company in this Agreement with respect to environmental matters (including Environmental Laws and Hazardous Substances).

Employees.

The Company Disclosure Letter contains a list of all persons who are employees, independent contractors or consultants of the Company and its Subsidiaries as of the date hereof who earn an annual base salary, wages, or annual fee, as the case may be, in excess of $200,000, including any employee who is on a leave of absence of any nature, paid or unpaid, authorized or unauthorized, and sets forth for each such individual the following: (i) employee ID; (ii) title or position (including whether full or part time); (iii) hire date; (iv) current annual base compensation rate; (v) commission, bonus or other incentive-based compensation; and (vi) leave status.

All material Contracts with the directors, officers and other key personnel or independent contractors of the Company and its Subsidiaries have been administered in accordance with their terms, in all material respects, and true, correct and complete copies of each such Contract are available in the Data Room Information. The Company and its Subsidiaries are in compliance, in all material respects, with all terms and conditions of employment applicable to the Company employees and all Law respecting labour and employment in all locations where such Company Employees work, including pay equity, wages, hours of work, unemployment insurance, discrimination, harassment, leaves of absence, equal opportunity, overtime, employment and labour standards, labour relations, human rights, privacy, the Worker Adjustment and Retraining Notification Act (or similar state or local Law), workers’ compensation and occupational health and safety, and, as of the date of this Agreement, there are no outstanding material Proceedings or complaints under any such Law.

There are no change of control payments, golden parachutes, severance payments, notice payments or payments in lieu of notice, funding of benefits, retention payments or agreements with any of the Company Employees providing for cash or other compensation or benefits upon, or in connection with, the consummation of the Arrangement or any other transaction contemplated by this Agreement (excluding any payments contemplated by the Arrangement or any other transaction contemplated by this Agreement) that may be owed to any Company Employee by the Company or its Subsidiaries if their relationship with the Company or any of its Subsidiaries is terminated on or following the consummation of the Arrangement or any other transaction contemplated by this Agreement (other than severance payments, notice payments or payments in lieu of notice owed, that are immaterial or that may be owed under Law).

As of the date of this Agreement (i) there are no material outstanding assessments, penalties, fines, liens, charges, surcharges, or other amounts due or owing pursuant to any workers’ compensation legislation and none of the Company or their Subsidiaries have been assessed or reassessed in any material respect under such legislation during the past four (4) years, (ii) to the knowledge of the Company, no audit of the Company or any Subsidiary is currently being

performed pursuant to any applicable workers’ compensation legislation and (iii) there are no claims or, to the knowledge of the Company, potential claims which may materially adversely affect the accident cost experience in respect of the Company.

As of the date of this Agreement, to the knowledge of the Company, there are no material charges pending under occupational health and safety Laws (“OHSA”) and there are no appeals of any orders under OHSA currently outstanding.

Collective Agreements.

Except as disclosed in the Company Disclosure Letter, there are no Collective Agreements in force with respect to any Company Employees.

No union has an application outstanding to have the Company or any Subsidiary declared a common or related employer under applicable labour legislation.

There is no labour strike, dispute, lock-out, concerted refusal to work overtime, work slowdown, stoppage or similar labour activity or organizing campaign pending or involving or, to the knowledge of the Company, threatened against the Company or any Subsidiary, except as would not reasonably be expected to have a Material Adverse Effect. None of the Company or, to the knowledge of the Company, any of its Subsidiaries is or has engaged in, or received notice of any, pending or threatened unfair labour practice complaint.

Employee Plans.

The Company has made available to Buyer correct and complete copies, as applicable, of: (i) the PSG Plan and the DSU Plan and each material written Employee Plan (or a summary of each unwritten plan), including any “employee benefit plan” as defined in Section 3(3) of the Employee Retirement Income Security Act of 1974, as amended (“ERISA”); (ii) the most recent annual reports on Form 5500 required to be filed with the IRS with respect to each material Employee Plan (if any such report was required); (iii) the most recent summary plan description for each material Employee Plan for which such summary plan description is required; (iv) each trust agreement and insurance or group annuity contract relating to any material Employee Plan; (v) all material correspondence to or from any Governmental Entity in the last three years relating to any material Employee Plan; (vi) all non-discrimination tests for the most recent plan year of any material Employee Plan; and (vii) the most current Internal Revenue Service approval (National Office Opinion and/or favourable determination letter) for any material Employee Plan intended to be qualified under Section 401(a) of the Code.

Except as disclosed in the Company Disclosure Letter, neither the execution of this Agreement nor any of the transactions contemplated by this Agreement will

increase the amount payable under or result in any other material obligation pursuant to any Employee Plan or any individual Contract with any Company Employee.

Each Employee Plan, the PSG Plan and the DSU Plan are and have been, in all material respects, established, registered, qualified, funded and administered in accordance with Law and in accordance with their terms. To the knowledge of the Company, no fact or circumstance exists which could adversely affect the registered or qualified status of any such Employee Plan.

To the knowledge of the Company, no event has occurred and no condition or circumstance exists that has resulted in or could reasonably be expected to result in any material Employee Plan being ordered, or required to be, terminated or wound up in whole or in part, having its registration under applicable Laws refused or revoked, being placed under the administration of any trustee or receiver or Governmental Entity or being required to pay any material taxes, penalties, payments or levies under applicable Laws.

Other than as required by Law, none of the Employee Plans provide for post-termination welfare benefits to any individual for any reason and neither the Company nor any of its ERISA Affiliates has any Liability to provide post-termination or retiree welfare benefits to any individual or ever represented, promised or contracted to any individual that such individual would be provided with post-termination or retiree welfare benefits.

Other than claims in the Ordinary Course (including routine claims for benefits), to the knowledge of the Company, no Employee Plan is subject to, or within the past three years, has been subject to, any Proceeding initiated or reasonably expected to be initiated by any Governmental Entity, or by any other party.

No Employee Plan is a multi-employer pension plan as such term is defined under the Pension Benefits Act (Ontario) or Section 3(37) of ERISA or any similar plan for purposes of pension standards legislation of another jurisdiction. Neither the Company nor any of its Subsidiaries or ERISA Affiliates sponsors, maintains or contributes to, or is obligated to contribute to, or has, within the preceding six years, sponsored, maintained or contributed to, a defined benefit pension plan or a multiple employer pension plan or multi-employer pension plan, including a “registered pension plan” or “multi-employer pension plan” within the meaning of the Tax Act or applicable pension standards legislation, or any plan which is subject to Section 412 of the Code or Section 302 or Title IV of ERISA.

As of the date of this Agreement, neither the Company nor any Subsidiary has any material liability (not reasonably expects to incur any material liability) for any assessment, excise or penalty taxes with respect to any plan or Employee Plan, including any “welfare benefit plan” within the meaning of Section 3(1) of ERISA or under Title IV of ERISA.

Only Company Employees or directors participate in the Employee Plans, and no entity other than the Company or its Subsidiaries is a participating employer under any Employee Plan. All Employee Plans are sponsored by the Company, its Subsidiaries or their respective affiliates.

Except as would not reasonably be expected to result in, individually or in the aggregate, a Material Adverse Effect, each Employee Plan that is subject to Section 409A of the Code has been administered in compliance with its terms and the operational and documentary requirements of Section 409A of the Code and all applicable regulatory guidance (including notices, rulings and proposed and final regulations) thereunder. The Company does not have any obligation to gross up, indemnify or otherwise reimburse any individual for any excise taxes, interest or penalties incurred pursuant to Section 409A of the Code.

Insurance.

As of the date of this Agreement, the Company and each of its Subsidiaries is insured by reputable third party insurers with reasonable and prudent policies appropriate for the size and nature of the business of the Company, taken as a whole, consistent with industry practice.

Each material insurance policy of the Company and its Subsidiaries currently in effect is in full force and effect and the Company and its Subsidiaries are not in default under the terms of any such policy. To the knowledge of the Company, there is no material claim pending under any insurance policy of the Company or its Subsidiaries that has been denied, rejected, questioned or disputed by any insurer or as to which any insurer has refused to cover all or any material portion of such claims. To the knowledge of the Company, all material Proceedings covered by any insurance policy of the Company or any of its Subsidiaries have been properly reported to and accepted by the applicable insurer.

Taxes.

The Company and each of its Subsidiaries have duly and timely filed with the appropriate Governmental Entity all material Tax Returns required by Law to be filed by them prior to the date hereof and all such Tax Returns are complete and correct in all material respects.

The Company and each of its Subsidiaries have paid as required by Law on a timely basis all material Taxes which are due and payable, all assessments and reassessments, and all other material Taxes due and payable by them, including instalments on account of Taxes for the current year, whether or not shown as being due on any Tax Returns or assessed by the appropriate Governmental Entity, on or before the date hereof, other than those which are being or have been contested in good faith by appropriate Proceedings and in respect of which adequate reserves have been provided in the most recently published consolidated

financial statements of the Company (where required in accordance with applicable accounting standards). The Company and its Subsidiaries have provided adequate accruals in accordance with their books and records and in the most recently published consolidated financial statements of the Company for any Taxes of the Company and each of its Subsidiaries for the period covered by such financial statements that have not been paid whether or not shown as being due on any Tax Returns. Since such publication date, no liability in respect of material Taxes not reflected in such statements or otherwise provided for has been assessed, proposed to be assessed, incurred or accrued.

No claims, audits, deficiencies, litigation, proposed adjustments or matters in controversy exist or have been asserted with respect to material Taxes of the Company or any of its Subsidiaries and none of the Company or any of its Subsidiaries is a party to any material Proceeding for assessment or collection of Taxes and no such event has been asserted or threatened against the Company or any of its Subsidiaries or any of their respective assets.

No claim has been made by any Governmental Entity in a jurisdiction where the Company or any of its Subsidiaries do not file Tax Returns that the Company or any of its Subsidiaries is or may be subject to Tax by that jurisdiction.

There are no Liens (other than Permitted Liens) with respect to Taxes upon any of the assets of the Company or any of its Subsidiaries.

The Company and each of its Subsidiaries has withheld or collected all material amounts required by Law to be withheld or collected by them on account of Taxes (including Taxes and other amounts required to be withheld by them in respect of any amount paid or credited or deemed to be paid or credited by them to or for the benefit of any Person and all amounts on account of any sales, use or transfer Taxes, including goods and services, harmonized sales, provincial and territorial taxes and state and local taxes, required by Law to be collected by them) and have remitted all such amounts to the appropriate Governmental Entity when required by Law to do so.

None of the Company or any of its Subsidiaries is bound by, is party to, or has any obligation under any Tax sharing, allocation, indemnification or similar agreement with respect to Taxes that could give rise to a payment or indemnification obligation (other than agreements among the Company and its Subsidiaries).

None of the Company or any of its Subsidiaries has, at any time, directly or indirectly transferred any property or supplied any services to, or acquired any property or services from, a Person who is not resident in Canada for purposes of the Tax Act and with whom the Company or Subsidiary, as the case may be, was not dealing at arm’s length (within the meaning of the Tax Act) for consideration other than consideration equal to the fair market value of such property or

services at the time of transfer, supply or acquisition, as the case may be, nor has the Company or any of its Subsidiaries been deemed to have done so for purposes of the Tax Act; and the Company and each such Subsidiary have made or obtained records or documents that meet the requirements of paragraphs 247(4)(a) to (c) of the Tax Act, and there are no transactions to which subsection 247(2) or subsection 247(3) of the Tax Act may reasonably be expected to apply.

There are no circumstances existing which could result in the application of Section 78 or Sections 80 to 80.04 of the Tax Act, or any equivalent provision under provincial Law, to the Company or any of its Subsidiaries. The Company and its Subsidiaries have not claimed nor will they claim any reserve under any provision of the Tax Act or any equivalent provincial provision, if any amount could be included in the income of the Company or its Subsidiaries for any period ending after the Effective Date.

For the purposes of the Tax Act, any applicable Tax treaty and any other relevant Tax purposes:

the Company is resident in Canada; and

each of its Subsidiaries is resident in the jurisdiction in which it was formed, and is not resident in any other country.

The Tax attributes of the depreciable assets of the Company and each of its Subsidiaries are accurately reflected in the Tax Returns of the Company and each of its Subsidiaries, as applicable, and have not materially and adversely changed since the date of such Tax Returns.

There are no outstanding agreements, arrangements, waivers or objections extending the statutory period or providing for an extension of time with respect to the assessment or reassessment of material Taxes of or the payment or remittance of material Taxes by, the Company or any of its Subsidiaries.

None of the Company or any of its Subsidiaries will be required to include any material item of income in, or exclude any material item of deduction from, taxable income for any taxable period (or portion thereof) ending after the Effective Date as a result of any:

change in method of accounting for a taxable period ending on or prior to the Effective Date;

use of an improper method of accounting for a taxable period ending on or prior to the Effective Date;

“closing agreement” as described in Section 7121 of the Code (or any corresponding or similar provision of state, local, or non-U.S. income Tax law) executed on or prior to the Effective Date;

intercompany transactions or any excess loss account described in U.S. Treasury Regulations under Section 1502 of the Code (or any corresponding or similar provision of state, local, or non-U.S. income Tax law);

installment sale or open transaction disposition made on or prior to the Effective Date;

prepaid amount received on or prior to the Effective Date; or

election under Section 108(i) of the Code.

Within the past 3 years, neither the Company nor any of its Subsidiaries has distributed stock of another Person, or has had its stock distributed by another Person, in a transaction that was purported or intended to be governed in whole or in part by Section 355 or 361 of the Code.

None of the Company or any of its Subsidiaries is or has been a party to any “listed transaction,” as defined in Section 6707A(c)(2) of the Code.

None of the Company or any of its Subsidiaries has been a United States real property holding corporation, within the meaning of Section 897(c)(2) of the Code, during the applicable period specified in Section 897(c)(1)(A)(ii) of the Code.

Brokers. Except for Scotia Capital Inc., no investment banker, broker, finder, financial adviser or other intermediary has been retained by or is authorized to act on behalf of the Company or any of its Subsidiaries or is entitled to any brokerage fee, commission, financial advisory fee or similar fee from the Company or any of its Subsidiaries in connection with this Agreement or any other transaction contemplated by this Agreement. The Company disclosed in the Disclosure Letter all material fees, commissions or other payments that may be payable to Scotia Capital Inc. in connection with this Agreement or any other transactions contemplated by this Agreement.

Fairness Opinion. The Board has received the Fairness Opinion.

Anti-Terrorism Laws. None of the Company or its Subsidiaries nor, to the knowledge of the Company, any director, officer, broker, employee, affiliate or other agent of the Company acting in any capacity in connection with the Arrangement and the other transactions contemplated hereby has been or is currently subject to any economic or financial sanctions or trade embargoes imposed, authorized, administered or enforced by the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”) (including, but not limited to, the designation as a “specially designated national or blocked person” thereunder), the Government of Canada or any other applicable sanctions authority (collectively, “Sanctions”), other than any laws, sanctions or trade embargoes of general applicability, or has acted, whether directly or indirectly, in violation of any Sanctions.

Corrupt Practices Legislation. None of the Company or any of its Subsidiaries or, to the knowledge of the Company, any of its or their respective directors, officers or employees acting on behalf of the Company or any of its Subsidiaries has taken, committed to take or been alleged to have taken any action which would cause the Company or any of its Subsidiaries to be in violation of the Corruption of Foreign Public Officials Act (Canada), the United States Foreign Corrupt Practices Act of 1977, the U.K. Bribery Act of 2010 or any Law of similar effect (collectively, “Corrupt Practices Legislation”). None of the Company or any of its Subsidiaries has received any written notices of that the Company or its Subsidiaries has violated any Sanctions or of a violation of any Corrupt Practices Legislation.

Privacy. Except as would not, individually or in the aggregate, have a Material Adverse Effect, (i) the Company and each of its Subsidiaries is, and since January 1, 2014 has been, conducting its business in compliance with all Privacy and Data Security Requirements governing privacy and the protection of personally identifiable information (“PII”), (ii) the Company has a written privacy policy which governs the collection, use and disclosure of PII, and the Company and its Subsidiaries are in compliance in all material respects with such policy, (iii) since July 1, 2015, there have not been, to the knowledge of the Company, any (a) losses or thefts of, or security breaches relating to, PII in the possession, custody or control of the Company or any of its Subsidiaries; (b) unauthorized access or unauthorized use of any such personally identifiable information; and (c) improper disclosure of any PII in the possession, custody or control of the Company or any Subsidiary or any Person acting on their behalf, and (iv) to the knowledge of the Company, as of the date hereof, none of the Company or any of its Subsidiaries is under investigation by any Governmental Authority for a violation of any Privacy and Data Security Requirements.

No “Collateral Benefit”. To the knowledge of the Company, no related party of the Company (within the meaning of MI 61-101) together with its associated entities, beneficially owns or exercises control or direction over 1% or more of the outstanding Shares, except for related parties who will not receive a “collateral benefit” (within the meaning of such instrument) as a consequence of the transactions contemplated by this Agreement.

Board and Special Committee Approval.

As of the date hereof, the Special Committee, after consultation with legal and financial advisors, has unanimously recommended that the Board approve the Arrangement and recommend to Shareholders that they vote in favor of the Arrangement Resolution.

As of the date hereof, the Board, after consultation with legal and financial advisors, has: (i) determined that the Consideration to be received by the Common Shareholders pursuant to the Arrangement is fair to the Common Shareholders and that the Arrangement is in the best interests of the Company; (ii) resolved to unanimously recommend that the Common Shareholders vote in

favour of the Arrangement Resolution; and (iii) authorized the entering into of this Agreement and the performance by the Company of its obligations under this Agreement, and no action has been taken to amend, or supersede, such determinations, resolutions or authorizations.

Each of the directors and executive officers of the Company has advised the Company that they intend to vote or cause to be voted all Common Shares beneficially held by them in favour of the Arrangement Resolution and the Company shall make a statement to that effect in the Company Circular.

Funds Available. At the Effective Date, the Company will have sufficient funds available to satisfy the Termination Fee, if any, in connection with the Arrangement in accordance with the terms of this Agreement, and to satisfy all other obligations payable by the Company and its Subsidiaries pursuant to this Agreement and the Arrangement and to pay all related fees and expenses for which the Company is responsible under the terms of this Agreement.

Disclosure. True and complete copies of all documents listed in the Company Disclosure Letter have been made available in the Data Room or provided to the Purchaser.

Organization and Qualification. The Purchaser is a corporation duly incorporated and validly existing under the laws of the jurisdiction of its incorporation and has all requisite power and authority to own, lease and operate its assets and properties and conduct its business as now owned and conducted. The Purchaser is duly qualified to carry on business and is in good standing in each jurisdiction in which its assets and properties, owned, leased or otherwise held, or the nature of its activities makes qualification necessary.

Corporate Authorization. The Purchaser has the requisite corporate power and authority to enter into this Agreement and the agreements and other documents to be entered into by it hereunder and to perform its obligations hereunder and thereunder. The execution, delivery of this Agreement and the agreements and other documents to be entered into by it hereunder and the performance by the Purchaser of its obligations hereunder and thereunder and the consummation of the Arrangement and the other transactions contemplated hereby have been duly authorized by all necessary corporate action on the part the Purchaser and no other corporate proceedings on the part the Purchaser are necessary to authorize this Agreement or the consummation of the Arrangement and the other transactions contemplated hereby.

Execution and Binding Obligation. This Agreement has been duly executed and delivered by the Purchaser, and constitutes a legal, valid and binding agreement of the Purchaser enforceable against it in accordance with its terms subject only to any limitation under bankruptcy, insolvency, reorganization, moratorium or other Laws related to or affecting the rights of creditors generally and the discretion that a court may exercise in the granting of equitable remedies such as specific performance and injunction.

Governmental Authorization. The execution, delivery and performance by the Purchaser of its respective obligations under this Agreement and the consummation by the Purchaser of the Arrangement and the other transactions contemplated hereby do not require any Authorization or other action by or in respect of, or filing with, or notification to, any Governmental Entity by the Purchaser other than: (a) the Required Regulatory Approvals; (b) the Interim Order, the Final Order and the filing of the Certificate of Arrangement or Articles of Arrangement; and (c) any Authorizations or other actions by or in respect of, or filings with, or notifications to, any Governmental Entity which, if not obtained, taken or made, would not, individually or in the aggregate, materially impede or delay the ability of the Purchaser to consummate the Arrangement and the transactions contemplated hereby.

Non-Contravention. The execution, delivery and performance by the Purchaser of its obligations under this Agreement and the consummation of the Arrangement and the transactions contemplated hereby do not and will not:

contravene, conflict with, or result in any violation or breach of the organizational documents of the Purchaser;

assuming compliance with the matters referred to in Paragraph (4) above, contravene, conflict with or result in a violation or breach of any Law applicable to the Purchaser or any of its properties or assets except as would not, individually or in the aggregate, materially impede or delay the ability of the Purchaser to consummate the Arrangement and the transactions contemplated hereby; or

result in the creation or imposition of any Lien (other than Permitted Liens) upon any of the material properties or material assets of the Company or its Subsidiaries (excluding, for greater certainty, any Lien created or imposed by the Debt Financing).

Litigation. There are no Proceedings pending or threatened against the Purchaser or, to the knowledge of the Purchaser, any of its affiliates, nor is the Purchaser or any of its affiliates subject to any outstanding judgment, order, writ, injunction, decree or award that, either individually or in the aggregate, is reasonably likely to prevent or materially delay consummation of the Arrangement or the transactions contemplated hereby.

Funds Available. Prior to the execution and delivery of this Agreement, the Purchaser has delivered to the Company (a) a true and complete, fully-executed copy of the Debt Commitment Letter evidencing the availability of committed credit facilities in favour of the Purchaser, pursuant to which the Lenders have agreed, subject to the terms and conditions set forth therein, to provide the Purchaser with the Debt Financing in the aggregate amount set forth therein (subject to the redaction provisions below with respect to the fee letters), and (b) a true and complete, fully-executed copy of the Equity Commitment Letter, pursuant to which the Equity Investors have agreed, subject to the terms and conditions set forth therein, to provide the Purchaser with funds in the aggregate amount set forth therein. Except for fee letters (complete copies of which have been provided to the Company, with only fee amounts, economic terms, “market flex” provisions and other customary threshold amounts redacted; provided that the Purchaser represents and warrants that the redacted provisions in such fee letters do not permit the imposition of any new conditions (or the expansion of any existing conditions) with respect to the Debt Financing or any reduction in the amount of the Debt Financing) and customary fee credit letters or engagement letters, in each case, with respect to the Debt Financing (none of which adversely affect the conditionality, enforceability, termination or availability of the Debt Financing or reduce the Debt Financing below the Required Amount, after taking into account the Equity Financing on the Effective Date), as of the date hereof, there are no other agreements, side letters or arrangements that would permit the Lenders to reduce the amount of the Debt Financing or that could otherwise affect the availability of the Debt Financing. The Debt Commitment Letter and the Equity Commitment Letter and any related fee letter contain all of the conditions precedent to the obligations of the parties thereunder to make the Financings available to the Purchaser on the terms therein. To the knowledge of the Purchaser, each Equity Investor has the financial capacity to pay and perform its obligations under the Equity Commitment Letter. As of the date hereof, each of the Debt Commitment Letter and the

Equity Commitment Letter is in full force and effect, has not been amended, restated, modified, withdrawn or terminated, and to the knowledge of the Purchaser (i) no amendment, restatement, withdrawal or termination is contemplated and (ii) no event has occurred or circumstance exists, including the execution, delivery and performance of this Agreement or the consummation of the transactions contemplated hereby, which, with or without notice, lapse of time or both, would or would reasonably be expected to constitute a default or breach on the part of the Purchaser under either the Debt Commitment Letter or the Equity Commitment Letter. Each of the Debt Commitment Letter and the Equity Commitment Letter, is a legal, valid and binding obligation of the Purchaser and, to the knowledge of the Purchaser, the other parties thereto, in each case, except as may be limited by (A) bankruptcy, insolvency, reorganization, moratorium, fraudulent conveyance or other similar Laws relating to creditors’ rights generally, and (B) general principles of equity, whether such enforceability is considered in a proceeding in equity or at law. As of the date hereof, assuming satisfaction of the conditions precedent set forth in Section 6.1 and Section 6.2 (other than those conditions that by their nature are to be satisfied at the Effective Time, but subject to the satisfaction or waiver of those conditions at the Effective Time), the Purchaser has no reason to believe that any of the conditions to the Financings contemplated by the Debt Commitment Letter and the Equity Commitment Letter will not be satisfied or that the Financings will not be made available to the Purchaser on the Effective Date, including any reason that would reasonably be expected to result in any of the conditions set forth in either the Debt Commitment Letter and the Equity Commitment Letter not being satisfied; that would constitute a material breach of any term or condition of the Debt Commitment Letter or the Equity Commitment Letter by any party thereto; or that would make the Purchaser unable to satisfy on a timely basis any condition of closing to be satisfied by it contained in the Debt Commitment Letter or the Equity Commitment Letter. All commitment and other fees or expenses required to be paid under or in connection with the Debt Commitment Letter and/or the Equity Commitment Letter on or prior to the date hereof have been paid. At the Effective Date, assuming the Financings contemplated in the Debt Commitment Letter and the Equity Commitment Letter are funded, the Purchaser will have sufficient funds available to satisfy the aggregate Consideration for the Common Shares and any other amounts payable to the Company Securityholders by the Purchaser and the Company in connection with the Arrangement in accordance with the terms of this Agreement (the “Required Amount”). The Equity Commitment Letter provides, and will continue to provide, that the Company is a third-party beneficiary thereof, and is entitled to enforce such agreement, subject to the terms and conditions thereof.

Security Ownership. Other than 7,599,518 Common Shares owned by the Purchaser or its affiliates, none of the Purchaser or any of its affiliates or any Person acting jointly or in concert with any of them owns any securities of the Company.

ICA Status. The Purchaser is not a “non-Canadian” as defined pursuant to Section 3 of the ICA.

Finders or Brokers. Except for BMO Capital Markets Inc., the Purchaser has not directly or indirectly employed any investment banker, broker or finder in connection

with the transactions contemplated by this Agreement or the Arrangement who or which would be entitled to any fee or any commission in connection with or upon consummation of the Arrangement.

Certain Arrangements. Except as disclosed to the Company, there are no contracts, undertakings, commitments, arrangements or understandings, whether written or oral, between the Purchaser or any of its affiliates, on the one hand, and any beneficial owner of outstanding Common Shares or Company Debentures or any member of the Company’s management or the Board, on the other hand, relating in any way to the Company, the Company’s securities, the transactions contemplated by this Agreement, the Arrangement, the Arrangement Resolution, or to the operations of the Company after the Effective Time.

Guarantee. Concurrently with the execution of this Agreement, the Purchaser has caused the Guarantors to deliver to the Company a duly executed Guarantee. The Guarantee is in full force and effect, is a valid, binding and enforceable obligation of each of the Guarantors and no event has occurred which, with or without notice, lapse of time or both, would constitute a default on the part of either of the Guarantors under the Guarantee.

to vote or to cause to be voted the common shares in the capital of the Company owned (beneficially or otherwise) as of the record date for the Company Meeting (the “Holder Securities”), in favour of the Arrangement and any other matter necessary for the completion of the Arrangement (including in favour of all matters recommended by management of the Company);

except as contemplated by the Arrangement Agreement or upon the settlement of awards or the exercise of other rights to purchase Common Shares, not to, directly or indirectly, acquire or seek to acquire Common Shares or other voting securities of the Company, or sell, assign, transfer, dispose of, hypothecate, alienate, grant a security interest in, encumber or tender to offer, transfer any economic interest (directly or indirectly) or otherwise convey any of the Holder Securities, in each case without the Purchaser’s prior written consent (such consent not to be unreasonably withheld, conditioned or delayed);

not to exercise any rights of dissent in connection with the Arrangement; and

except as required pursuant to this Agreement (including to give effect to clause (a) above), not to grant or agree to grant any proxy or other right to vote the

Holder Securities or enter into any voting trust or pooling agreement or arrangement in respect of the Holder Securities or enter into or subject any of the Holder Securities to any other agreement, arrangement, understanding or commitment, formal or informal, with respect to or relating to the voting or tendering thereof or revoke any proxy granted pursuant to this Agreement.

(Name and Title)

By:

Name:

Title: